transcript human melanoma identifi gene signatur aggress melanoma metastas leifidl metastasi deadliest phase cancer progress experiment model immunodefici mice have been gain insight mechan metastasi report identif metastasi aggress gene express signatur deriv human melanoma cell select base their metastat potenti xenotranspl metastasi model comparison express data human melanoma patient show metastasi gene signatur correl aggress melanoma metastas human patient mani gene encod secret membran protein includ signatur suggest import tumormicroenviron interact dure metastasi experi parent cell line vs xenograft model homo sapien
transcript human sequenti breast cancer biopsi dure letrozol treatment  present investig have exploit opportun provid neoadjuv treatment group postmenopaus women larg oper local advanc breast cancer therapi given primari tumour remain within breast take sequenti biopsi same cancer befor after day treatment letrozol rna extract biopsi been subject affymetrix microarray analysi data pair biopsi interrog discov gene whose express most influenc oestrogen depriv experi biopsi taken same subject both pretreat after day letrozol mgday oral homo sapien
transcript human muscl untreat children juvenil dermatomyos background evalu impact durat chronic inflamm gene express skelet muscl biopsi mbx untreat children juvenil dermatomyos jdm identifi gene biolog process associ diseas progress express data girl activ symptom jdm greater equal month compar girl activ symptom less than month result seventynin gene differenti express between group long short durat untreat diseas gene involv immun respons vasculatur remodel express higher level muscl biopsi children greater equal month symptom while gene involv stress respons protein turnov express lower level among gene express gene show signific linear regress relationship durat untreat diseas five differenti express geneshladqa smooth muscl myosin heavi chain cluster plexin tenomodulinwer verifi quantit rtpcr chronic inflamm longer diseas durat also associ increas dclamp bdca matur dendrit cell identifi immunohistochemistri conclus conclud chronic inflamm alter gene express pattern muscl untreat children jdm symptom last greater equal month associ dendrit cell matur antiangiogen vascular remodel direct contribut diseas pathophysiolog experi after obtain inform consent girl definit jdm enrol studi prior obtain mri direct diagnost muscl biopsi all jdm sampl healthi age sexmatch control express first gene filter onli data untreat patient then analyz statist experi diseas durat less than month yjdjdmuasyjdjdmuasyjdjdmuas experi diseas durat more than monthsyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuasyjdjdmuas homo sapien
transcript esophagus sampl eight human patient barrett associ adenocarcinoma sampl obtain patient barrett associ adenocarcinoma after transhiat esophagectomi sampl repres normal esophag epithelium barrett esophagus esophag adenocarcinoma adc obtain everi patient experienc gi pathologist rna extract sampl detect gene differenti express adc relat adc relat esophagus homo sapien patient patient patient patient patient patient patient patient esophag adenocarcinoma barrett esophagus normal
transcript human prostat cancer cell normal epitheli prostat cell stroma cell patient placebo selenium vitamin selenium vitamin treatment group  radic prostatectomi specimen where sampl placebo group pl selenium group se vitamin group ve vitamin selenium group vstreatment group lselenomethionin ug placebo vitamin vitamin iu placebo lselenomethionin lselenomethionin ug vitamin iu placebo subject laser captur microdissect isol prostat cancer cell normal epitheli prostat cell stroma cell rna extract amplif perform transcript conduct hgua affymetrix array adult prostat male epitheli cell stroma tumor frozensampl homo sapien pobfccp ntpobfccp ntpobfccp pobfccp pobfccp pobfccp ntpobfccp pobfccp pobfccp ntpobfccp pobfccp pobfccp ntpobfccp pobfccp ntpobfccp pobfccp pobfccp pobfccp ntpobfccp pobfccp ntpobfccp pobfccp pobfccp pobfccp pobfccp pobfccp pobfccp ntpobfccp pobfccp ntpobfccp ntpobfccp pobfccp ntpobfccp pobfccp pobfccp pobfccp not applic not applic prostat cancer tumor normal
transcript advanc human breast cancer treat doseintens epirubicin cyclophosphamid regimen follow mastectomi  sampl hybrid affymetrix hgua array analysi advanc breast cancer treat doseintens epirubicin cyclophosphamid regimen follow mastectomi valid tprelat gene breast bladder cancer found complet respons chemotherapi onli observ tp mutant tumour further show among tp mutant tumour high basalcytokeratin low esr express level associ complet respons these observ pave way molecular tailor chemotherapi breast cancer mammari gland dnadamag chemotherapi homo sapien tpnotmut tpmutat esr absent erbb absent esr present year incomplet respons complet respons local advanc breast carcinoma labc noninflammatori
transcript human prostat cancer sampl prostat cancer gene express studi project total rna prostat sampl various amount differ cell type hybrid affymetrix ua array percentag differ cell type vari consider among sampl determin pathologist cell type specif gene determin linear regress method stuart et al pnas experi prostat sampl various amount tumor stroma bph atroph gland studi homo sapien
transcript human melanoma xenotranspl metastati model gene signatur aggress melanoma metastas metastasi deadliest phase cancer progress experiment model immunodefici mice have been gain insight mechan metastasi report identif metastasi aggress gene express signatur deriv human melanoma cell select base their metastat potenti xenotranspl metastasi model comparison express data human melanoma patient show metastasi gene signatur correl aggress melanoma metastas human patient mani gene encod secret membran protein includ signatur suggest import tumormicroenviron interact dure metastasi experi test signatur genereat experi parent cell line vs xenograft model homo sapien
transcript human diseas normal sampl multipl diseas test experi test homo sapien mus musculus
transcript human lung cancer sampl detect treatment predict outcom lung cancer patient increas depend molecular understand tumor develop sensit lung cancer therapeut drug applic genom technolog such microarray wide monitor global gene express built up invalu inform knowledg essenti discoveri new insight mechan common cancer cell result identif uniqu identifi signatur specif characterist like applic microarray revolution mani aspect lung cancer diagnos classifi treat near futur microarray detail global gene express pattern lung cancer experi adjac normaltumor match lung cancer sampl select earli late stage rna extract hybrid affymetrix microarray total sampl microarray analysi includ pairwis sampl patient underw surgeri lung cancer taipei veteran general hospit tissu mixtur taichung veteran general hospit adjac normal lung mixtur other lung adenocarcinoma mixtur commerci human normal lung tissu clontech catalog no stratagen catalog no immort nontumorigen human bronchial epitheli cell line nl atcc no crl lung cancer cell line atcc no ccl ncih atcc no crl ncih atcc no htb cl cl cl clf homo sapien
transcript human mcfamyc breast cancer cell line treat dexamethazon ethanol control sampl timepoint reveal glucocorticoid receptor activ signal through forkhead transcript factor   seri contain time cours microarray data mcfamyc cell treat either ethanol dexamethason min hr hr hr seri contain biolog replic analyz independ replic experi homo sapien mcfamyc cell breast cancer
transcript human invas breast carcinoma data analysi publish studi understand molecular basi histolog grade improv prognosi background histolog grade breast cancer provid clinic import prognost inform howev tumor classifi histolog grade grade associ intermedi risk recurr thus not inform clinic decis make examin whether histolog grade associ gene express profi les breast cancer whether such profi les could improv histolog grade method analyz microarray data invas breast carcinoma publish gene express dataset breast carcinoma identifi differenti express gene train estrogen receptor erposit tumor sampl compar express between histolog grade tumor histolog grade tumor express these gene defin gene express grade index data independ tumor evalu associ between relapsefre surviv gene express grade index kaplanmei analysi all statist test twosid result identifi gene train associ histolog grade most these gene involv cell cycl regul prolifer valid dataset gene express grade index strong associ histolog grade status howev among histolog grade tumor index span valu histolog grade tumor among patient histolog grade tumor high gene express grade index associ higher risk recurr than low gene express grade index hazard ratio confid interv logrank test conclus gene express grade index appear reclassifi patient histolog grade tumor group high versus low risk recurr approach improv accuraci tumor grade thus prognost valu nb patient come uppsala hospit have been also other studi gse you find common patient remov abbrevi upp sampl name compar result index id gse seri experi microarray experi primari breast tumor train identifi gene differenti express grade experi microarray experi primari breast tumor untreat patient valid valid list gene correl surviv experi no replic no refer sampl homo sapien
transcript human colorect serrat adenocarcinoma convent adenocarcinoma reveal they molecular subclass well morpholog distinct serrat adenocarcinoma morpholog differ convent adenocarcinoma serrat pathway recent been propos repres novel mechan colorect cancer crc format howev whether they biolog differ truli form distinct subclass crc not known studi show gene express serrat convent crcs differ other serrat crcs not onli morpholog novel also biolog distinct subclass crc experi total rna extract fresh frozen tumor trizol gibcobrl purifi rneasi spin column qiagen rna qualiti analyz spectrophotomet agil bioanalyz agil technolog biotin label fragment crna prepar microgram total rna procedur recommend hgu genechip express analysi affymetrix hgua chip hybrid scan analyz microarray suit softwar accord manufactur instruct affymetrix male femal frozensampl homo sapien serrat colerect carcinoma colorect carcinoma
transcript human androgendepend androgenindepend primari prostat cancer tumor affymetrix ua comparison group sampl untreat androgendepend primari prostat cancer gleason androgenindepend primari prostat cancer all sampl microdissect tumor cell onli prostat frozensampl homo sapien gleason gleason gleason gleason gleason androgendepend prostat cancer androgenindepend prostat cancer
transcript human urinari superfici transit cell carcinoma surround carcinoma situ cis lesion without surround cis lesion muscl invas carcinoma  presenc carcinoma situ cis lesion urinari bladder associ high risk diseas progress muscl invas stage studi microarray express examin gene express pattern superfici transit cell carcinoma stcc surround cis patient without surround cis lesion patient muscl invas carcinoma mtcc patient hierarch cluster analysi separ stcc sampl accord presenc absenc cis surround urothelium identifi gene cluster contain gene similar express level transit cell carcinoma tcc surround cis invas tcc howev no close relationship between tcc adjac cis invas tcc observ hierarch cluster analysi express seri biopsi normal urothelium urothelium cis lesion same urinari bladder reveal gene express found stcc surround cis found also cis biopsi well histolog normal sampl adjac cis lesion furthermor also identifi similar gene express chang mtcc sampl supervis learn approach build gene molecular cis classifi classifi abl classifi stcc sampl accord presenc absenc surround cis high accuraci studi demonstr cis gene express signatur present not onli cis biopsi also stcc mtcc remark histolog normal urothelium bladder cis identif express signatur could provid guidanc select therapi followup regimen patient earli stage bladder cancer experi public bladder mucosa bladder homo sapien muscl invas carcinoma superfici transit cell carcinoma surround carcinoma situ lesion normal urothelium carcinoma situ lesion normal mucosa superfici transit cell carcinoma without surround carcinoma situ lesion
transcript human rhabdomyosarcoma biopsi sampl embryon rms translocationposit alveolar rms translocationneg alveolar rms  measur express seri rhabdomyosarcoma biopsi sampl embryon rms translocationposit alveolar rms translocationneg alveolar rms express data unsupervis hierarch cluster well supervis analysi find gene express signatur characterist differ histolog rms subgroup biopsi homo sapien embryon rhabdomyosarcoma alveolar rhabdomyosarcoma
transcript human neuroblast tumour reveal distinct gene signatur identifi malign neuroblast schwannian stromal cell tumor tissu heterogen well known featur sever solid tumor neuroblast tumor nts group paediatr cancer great tissu heterogen most nts compos undifferenti poor differenti differenti neuroblast nb cell veri absent schwannian stromal ss cell these tumor group neuroblastoma schwannian stromapoor remain nts compos abund ss cell classifi ganglioneuroblastoma schwannian stromarich intermix nodular ganglioneuroma import understand nb ss gene signatur nts clarifi complex network mechan tumor growth progress order identifi nb ss cell gene signatur analyz gene express case neuroblast tumor stroma poor ntssp stroma rich ntssr high densiti oligonucleotid microarray moreov analysi perform parallel both whole laser microdissect tumor sampl case isol differ area all compos pure cellular popul perform genom wide express analysi affymetrix technolog differ approach data analysi sam signific analysi microarray method base game theori gt identifi gene differ express ss nb cell differ sam method analysi base gt moretti et al give advantag select relev gene not onli accord express singl gene consid also gene interact experi tissu sampl primari neuroblastoma stromapoor ntssp ganglioneuroblastomaganglioneuroma stromarich ntssr tumor obtain diagnosi patient differ clinic stage frozen sampl ntssp minimum content malign cell while ntssr more than schwannian stromal cell four out nts neuroblastoma schwannian stomapoor ganglioneublastoma schwannian stromarich further analyz laser microdissect homo sapien
transcript normal breast epithelium breast cancer patient reveal gene express abnorm normalappear epithelium cancer patient harbor occult genet abnorm data comprehens compar gene express between histolog normal breast epithelium breast cancer patient cancerfre control limit present studi compar global gene express between these group perform microarray rna microdissect histolog normal termin ductallobular unit tdlu group cancer normal cn tdlus adjac untreat er breast cancer reduct mammoplasti rm tdlus agematch women without breast diseas cybert identi differenti express gene quantit rtpcr qrtpcr immunohistochemistri ihc comparison independ microarray data includ carcinoma situ cis valid result gene ontolog go uniprot publish literatur evalu gene function about probeset correspond gene differenti express between cn rm correspond fdr probeset also differenti express between cis rm near alway same direct cn vs rm twothird gene implic previous carcinogenesi overrepres function group includ transcript gprotein coupl chemokin receptor activ mapk cascad immedi earli gene most gene these categori underexpress cn vs rm conclud global gene express abnorm exist normal epithelium breast cancer patient also present earli cancer thus cancerrel pathway perturb normal epithelium these abnorm could marker diseas risk occult diseas tissu respons exist tumor experi sampl histolog normal microdissect breast epithelium includ seri sampl epithelium adjac breast tumor sampl obtain patient undergo reduct mammoplasti without appar breast cancer homo sapien
transcript human colorect cancer wiskottaldrich syndrom predispos patient leukemia lymphoma caus mutat protein wasp impair interact wipf protein identifi modul wipfcoexpress gene assess prognost signatur colorect cancer glioma breast cancer patient public colorect cancer microarray data discoveri valid wipf coexpress modul base express wipf signatur classifi more than addit tumor microarray data own experi public avail data accord their wipf signatur express allow us separ patient popul colorect cancer breast cancer glioma clinic characterist like surviv time time relaps analyz group colorect cancer breast cancer glioma patient low express wipf coexpress modul general favor prognosi addit major wipf signatur gene individu correl diseas outcom differ studi literatur gene network analysi reveal among wipf coexpress gene known direct transcript target cmyc esr enrich mean express wipf signatur gene correl prolifer signatur wipf signatur first microarraybas prognost express signatur primarili develop colorect cancer instrument other tumor type low express wipf modul associ better prognosi microarray valid wipf coexpress modul develop public avail dataset experi generat own microarray data crc patient undergo elect standard oncolog resect depart general vascular thorac surgeri campus benjamin franklin charit prospect recruit homo sapien
transcript hepato cellular carcinoma tumor sampl hepatocellular adenoma nontumor pool  sampl affymetrix hgua genechip array tumor sampl hepatocellular adenoma nontumor pool identif subgroup hepatocellular carcinoma hcc close associ clinic genet annot esp risk factor genet alter identif gene diagnost predictor class membership well gene signatur predict patient prognosi irrespect hcc subgroup outperform common clinic prognost marker valid both gene signatur independ hcc liver femal male frozensampl homo sapien betacateninenotmut betacateninemut tpmutat hbvtiterlow hbvtiterneg hbvtiterhigh year nontumor hbv noncirrhot liver nontumor alcohol cirrhosi nontumor hcv cirrhosi hepatocellular adenoma satellitenodul hcc tumor nosatellitenodul nontumor hbv cirrhosi nontumor alcohol noncirrhot liver
transcript oral caviti sampl human squamous cell carcinoma patient metastasi lymphat major risk factor squamous cell carcinoma oral caviti oscc sought determin whether presenc metastasi region lymph node could predict gene express signatur primari tumor total oscc character gene express hybrid rna affymetrix ua gene chip gene differenti express identifi permut techniqu verifi quantit rtpcr immunohistochemistri predict rule built support vector machin accuraci rule evalu crossvalid origin data predict independ four patient metastat primari tumor could differenti nonmetastat primari tumor signatur gene gene signatur gene correct predict four independ patient well associ five lymph node metastas origin patient metastat primari tumor group conclud lymph node metastasi could predict gene express primari oral caviti squamous cell carcinoma presenc gene express signatur lymph node metastasi indic clinic test assess risk lymph node metastasi should possibl floor mouthtonsil mandibl floor mouthbucc larynx floor mouth lymph node metastasi tongu gingiva femal male homo sapien year tan tn tn tan tn tnb tnb tn tnc tnb tn tn tanb tn tan no metastasi metastasi squamous cell carcinoma
transcript human colon sampl patient have colorect cancer recurr recurrencefre identifi gene express classifi clinic outcom  sampl recurr free patient label patient colorect cancer tumor recurr label iv follow up month colon male femal frozensampl homo sapien colorect cancer recurr colorect cancer recurrencefre
gene express human osteosarcoma pulmonari metastasi continu most common caus death osteosarcoma inde year surviv newli diagnos osteosarcoma patient not signific chang over year further understand mechan metastasi resist aggress pediatr cancer necessari pet dog natur develop osteosarcoma provid novel opportun model metastasi develop progress given acceler biolog canin osteosarcoma hypothes direct comparison canin pediatr osteosarcoma express help identifi novel metastasisassoci tumor target have been miss through studi human cancer alon collect these data support strong similar between human canin osteosarcoma underlin opportun provid compar oncolog approach mean improv understand cancer biolog therapi experi human osteosarcoma normal tissu singl channel homo sapien
transcript human lung adenocarcinoma affymetrix human genom ua platform obtain gene express patholog clinic well character adenocarcinoma lung addit egfr status determin fluoresc situ hybrid immunohistochemistri classif case cluster algorithm appli express data correl signific histopatholog tumor grade contrast no correl gene express data egfr status could detect experi studi evalu gene express clinicopatholog well character lung adenocarcinoma homo sapien
transcript human transiliac bone biopsi patient primari hyperparathyroid pre post surgeri investig molecular patholog bone hyperparathyroid  analyz mrnas transiliac bone biopsi patient primari hyperparathyroid affymetrix hgua gene chip similar analys global transcript activ repeat second bone biopsi same patient taken year after surgeri revers diseas paramet bone femal male freshsampl homo sapien patient post op patient post op patient post op patient post op patient pre op patient pre op patient pre op patient pre op patient post op patient post op patient pre op patient pre op patient pre op patient post op year normal primari hyperparathyroid
transcript brain tumor cell assess endogen mrna fluctuat detect microrna signal vivo express mrnas background microrna mirna approxim nucleotid noncod transcript capabl regul gene express most wide studi mechan regul involv bind mirna target mrna usual untransl region utr result translat target mrna inhibit sometim mrna itself destabil inhibitori effect mirna have been link mani divers cellular process includ malign prolifer apoptosi develop differenti metabol process neural plastic ask whether endogen fluctuat mrna mirna contain correl chang statist distinguish mani other fluctuat data methodologyprincip find biopsi human primari brain tumor extract rna these sampl determin genomewid mrna express level microarray analysi mirna realtim revers transcript pcr rtpcr correl coeffici determin all possibl mrnamirna pair distribut these correl compar random distribut excess high posit negat correl pair observ tail these distribut most these highest correl pair do not contain suffici complementari sequenc predict target relationship nor do they lie physic proxim other howev examin pair signific correl coeffici modest relax negat correl do tend predict target posit correl do tend predict physic proxim pair subset high correl pair experiment valid overexpress suppress mirna measur correl mrnas conclusionssignific suffici inform exist within tumor sampl detect endogen correl between mirna mrna level base valid correl causal arrow these correl like direct mirna mrnas these data infer valid tumor suppress pathway link mirc experi microarray data obtain tumor affymetr hgua array platform tissu glioma resect obtain collect ucla under approv institut review board categor high low grade base formal patholog report grade iv term high grade grade term low grade histolog diagnos fell follow categori low grade anaplast mix glioma low grade oligodendroglioma high grade glioblastoma high grade gliosarcoma high grade glioblastomagliosarcoma homo sapien kh ic high grade glioblastoma high grade gliosarcoma low grade anaplast mix glioma low grade oligodendroglioma high grade glioblastomagliosarcoma
transcript human breast cancer sampl treat tamoxifen identifi gene signatur defin highrisk patient benefit adjuv tamoxifen therapi classif tamixifentr breast cancer patient high low risk group gene signatur experi breast cancer sampl treat tamoxifen classifi gene signatur homo sapien
transcript human pediatr malign germ cell tumor  compar transcriptom princip histolog variant malign germ cell tumor occur childhood experi analyz global gene express pediatr mgcts princip histolog yolk sac tumor ysts seminoma homo sapien
renal progenitor cell gene express  multipot progenitor cell mps have been observ human kidney particular bowman capsul proxim tubul kidney own abil repair local damag renal mps play role regen process microarray technolog appli identifi differenti express gene among resid mps isol glomeruli tubul normal renal tissu renal proxim tubular epitheli cell rptec mesenchym stem cell mscs result analysi repres start point further function studi experi studi includ renal tissu sampl process obtain glomerular progenitor popul tubular subcoltur mscs rptec includ well differ gene express pattern cell type found out homo sapien
transcript human burkitt lymphoma  distinct between burkitt lymphoma diffus larg bcell lymphoma imprecis current diagnost criteria appli transcript genom molecular defin burkitt lymphoma gene express employ affymetrix genechip ua perform matur aggress bcell lymphoma includ core group eight burkitt lymphoma fulfil all diagnost criteria classif molecular signatur burkitt lymphoma generat chromosom abnorm detect interphas fluoresc insitu hybrid array compar genom hybrid molecular burkitt lymphoma signatur identifi case fifteen these case lack morpholog typic burkittburkittlik lymphoma vast major lymphoma without molecular burkitt lymphoma signatur repres diffus larg bcell lymphoma these case myc break detect associ complex chromosom chang molecular definit burkitt lymphoma sharpen extend spectrum burkitt lymphoma matur aggress bcell lymphoma without burkitt lymphoma signatur chromosom break myc locus prove associ advers clinic outcom experi diffus larg bcell lymphoma burkitt lymphoma sampl hybrid hgua affymetrix genechip homo sapien
transcript human primari breast tumor mdamb subpopul subpopul mdamb exhibit differ metastat tropism inject immunodefici mice also cohort primari breast cancer surgic resect memori sloankett cancer center mskcc homo sapien
transcript colon cancer tumor normal biopsi seri patient identifi molecular biomark express studi colon cancer compar tumor normal biopsi seri patient order identifi molecular biomark year year year year year year year year year year year year year year year year year year year year year colon male femal frozensampl surgeri divis css hospit homo sapien individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu individu normal tumor
transcript human patient diffus larg bcell lymphoma treat chop ritxumabchop  sampl hybrid affymetrix hgua genechip array patient diffus larg bcell lymphoma dlbcl patient treat chop cyclophosphamid doxorubicin vincristin prednison ritxumab rchop group etud des lymphom de adult gela clinic center femal male rchop chop homo sapien year event free surviv year surviv year event free surviv year surviv year surviv year event free surviv year surviv year event status event free surviv year death status surviv year event free surviv year event free surviv year surviv year surviv year surviv year surviv year surviv year surviv year surviv year surviv year event free surviv year surviv year surviv year surviv year surviv year event free surviv year event free surviv year surviv year surviv year event free surviv year surviv year surviv year event free surviv year surviv year surviv year event free surviv year event free surviv year event free surviv year surviv year surviv year diffus larg bcell lymphoma
transcript mous heart implicatesosteoglycin ogn regul left ventricular mass left ventricular mass lvm cardiac gene express complex trait regul factor both intrins extrins heart dissect major determin lvm combin express quantit trait locus quantit trait transcript qtt analys cardiac transcriptom rat these method vitro function assay identifi osteoglycin ogn major candid regul rat lvm increas ogn protein express associ elev lvm also appli genomewid qtt analysi human heart observ out transcript ogn transcript abund highest correl lvm further confirm role ogn vivo regul lvm ogn knockout mice taken togeth these data implic ogn key regul lvm rat mice human suggest ogn modifi hypertroph respons extrins factor such hypertens aortic stenosi experi cardiac biopsi control patient cardiac biopsi aortic stenosi patient homo sapien
sirna human hela cell respons upf deplet nonsensemedi mrna decay nmd molecular pathway mrna surveil ensur rapid degrad mrnas contain prematur translat termin codon ptcs eukaryot origin nmd thought qualiti control pathway target nonfunct mrnas aris mutat splice error more recent nmd been shown also regul normal gene express nmd thus emerg key posttranscript mechan gene regul have now systemat analyz molecular mechan variabl nmd effici differ hela cell strain model system result analysi show nmd effici remark variabl repres stabl characterist these strain low nmd effici shown function relat reduc abund exon junction compon rnps hela strain analyz furthermor restor function rnps express not nmdinact mutant protein also restor effici nmd rnps defici cell line conclud cellular concentr rnps modifi nmd effici propos cell type specif cofactor avail repres novel principl control nmd experi hela cell treat upf sirna luciferas sirna negat control after hs cytoplasm rna isol integr rna assess agil bioanalyz agil palo alto ca perform prepar process hybridis label fragment crna target affymetrix hgua genechipstm accord manufactur protocol affymetrix inc santa clara ca oligonucleotid array scan confoc laser scanner genearraytm hewlett packard palo alto ca affymetrix genechip suit softwar mas calcul raw express valu probe ua oligonucleotid array signal intens calcul averag intens differ aid between perfect mismatch probe approxim probe continu result absent call exclud analys next genespr silicon genet redwood citi ca scale normalis background correct all gene array perform student ttest normalis relat express ratio identifi signific differenti express gene minimum factor differ fold within confid interv homo sapien
transcript human primari breast tumor valid gene prognost signatur reveal strong time depend gene prognost signatur background recent gene prognost signatur abl predict distant metastas lymph nodeneg breast cancer patient report studi conduct transbig independ valid these result compar outcom clinic risk assess materi method gene express frozen sampl system untreat patient perform bordet institut blind clinic data independ veridex genom risk defin veridex blind clinic data surviv analys done independ statistician perform genom risk adjust clinic risk defin adjuvantonlin result actual year time distant metastasi tdm respect good group poor group actual year surviv os respect good group poor group observ strong timedepend signatur lead adjust hr year year tdm os respect conclus independ valid confirm perform gene signatur add grow evid gene express signatur clinic relev especi identifi patient high risk earli distant metastas experi dataset microarray experi primari breast tumor valid gene signatur veridex no replic no refer sampl homo sapien
transcript human breast cancer cohort reveal humor immun system key prognost impact nodeneg breast cancer estrogen receptor er express prolif activ establish prognost factor breast cancer search addit prognost motiv analyz gene express pattern tumor patient not treat system therapi after surgeri discoveri approach after perform hierarch cluster analysi identifi coregul gene relat biolog process prolifer steroid hormon receptor express well cell cell infiltr calcul metagen surrog all gene contain within particular cluster visual relat express relat time metastasi princip compon analysi distinct pattern led hypothesi prognost role immun system tumor high express prolifer associ gene multivari cox regress analysi prolifer metagen show signific associ metastasisfre surviv whole discoveri cohort hazard ratio hr confid interv ci cell metagen show addit independ prognost inform carcinoma high prolif activ hr ci prognost influenc bcell metagen independ confirm multivari analysi first valid cohort enrich high grade tumor hr ci second valid cohort enrich younger patient hr ci thus could demonstr cohort untreat nodeneg breast cancer patient humor immun system play pivot role metastasisfre surviv carcinoma breast experi popul base untreat breast cancer cohort studi includ sampl homo sapien
transcript human primari gastric cancer express uk patient cohort genomewid mrna express primari gastric tumor uk patient cohort gastric cancer gc second lead caus global cancer mortal individu gastric tumor display signific heterogen their deregul various oncogen pathway identifi major oncogen pathway gc robust impact patient surviv treatment respons silico strategi base gene express signatur connect analyt map pattern oncogen pathway activ uniqu gc cell line primari gastric cancer independ patient cohort oncogen pathway previous implic gc identifi predomin pathway proliferationstem cell nfkb wntbcatenin deregul major gastric tumor varieti prolif wnt nfkbrelat assay experiment valid pathway predict multipl gc cell line show similar pathway activ pattern vitro patient stratifi level individu pathway not exhibit consist differ clinic outcom howev patient group oncogen pathway combin demonstr robust signific surviv differ eg high proliferationhigh nfkb vs low proliferationlow nfkb suggest tumor behavior gc like influenc combin effect multipl oncogen pathway result demonstr gcs success taxonom oncogen pathway activ biolog clinic relev subgroup experi primari gastric tumor affymetrix genechip human genom array hgua all tumor collect approv st jamess univers hospit unit kingdom research ethic review committe homo sapien
transcript human tumor stroma breast catur lcm inflammatori non inflammatori breast cancer tumor epithelium surround stromal cell isol laser captur microdissect human breast cancer examin differ gene express base tissu type inflammatori noninflammatori breast cancer experi appli lcm obtain sampl enrich tumor epithelium stroma ibc nonibc case studi relat contribut compon ibc phenotyp patient surviv homo sapien
express data biopsi nasopharyng carcinoma npc nonmalign control nasopharyng carcinoma npc common cancer southern china south east asia where more than new case diagnos year microarray identifi down upregul gene npc compar nonmalign control experi snap frozen nasopharyng biopsi patient histolog confirm undifferenti npc includ microarray analysi control obtain patient no evid malign homo sapien
transcript human non small cell lung cancer cell line non small cell lung cancer lead caus cancer relat mortal western world rna express have been demonstr associ specif clinic cours diseas microarray analysi captur whole transcriptom seri lung cancer cell line extract rna associ specif genom lesion experi lung cancer cell line exponenti grown harvest dure phase exponenti growth homo sapien
transcript human inflammatori breast carcinoma tumor lumin basal apocrin eortc phase clinic trial compar fec et patient larg oper local advanc inflammatori breast cancer wwweortcb frozen biopsi taken randomis rna extract um thick core needl biopsi adjac section test he confirm tumour cell content ng total rna per chip amplifi affymetrix small sampl protocol ivt then enzo tumour test affymetrix ua chip cel file quantil normalis togeth rma clinic respons data not avail doisjonc farmer et al identif molecular apocrin breast tumour microarray analysi apocrin tumor basal tumor lumin tumor homo sapien ting tng tngu tng tng tng tng tng ting tngu ting tng tng tng tng tng tng tng inflammatori breast carcinoma
transcript human cell type identifi gene respons cardiomyogen differenti  perform genechip analysi identifi multipl extracellular determin such cytokin cell membranebound molecul matrix respons cardiomyogen differenti evalu statist signific differenti gene express nia array analysi httplgsungrcnianihgovanova bioinformat webbas tool microarray data analysi experi identifi cytokin transcript factor respons cardiomyogen differenti human cell cluster group depend gene express level genespringgx softwar among group group includ cell cardiomyogen potenti identifi gene specif these group hierarch cluster employ grem nomin clusterspecif cardiomyocytepromot gene nia array analysi homo sapien
transcript human lung tissu sever emphysema versus normal mild emphysema human patient comparison sever emphysemat tissu remov lung volum reduct surgeri normal mild emphysemat lung tissu resect smoker nodul suspici lung cancer data obtain patient sever emphysema patient mildno emphysema research provid insight pathogenet mechan involv chronic obstruct pulmonari diseas copd lung homo sapien mild none sever emphysema
transcript human primari lung adenocarcinoma normal lung tissu sampl gene transcript human primari lung adenocarcinoma normal lung tissu sampl examin affymetrix genechip technolog investig differenti gene express between tissu type total gene call mad found either up downregul least fold between phenotyp gene assign particular gene ontolog term found mani case signific uneven distribut between gene outsid mad term overrepres mad includ function direct implic cancer cell metabol base their function role express gene mad group like coregul gene adult lung male femal frozensampl homo sapien year lung adenocarcinoma ncithesaurus diseasestag stage normal lung adenocarcinoma ncithesaurus diseasestag stage lung adenocarcinoma ncithesaurus diseasestag stage iv lung adenocarcinoma ncithesaurus diseasestag stage 
cypa gene express associ earli recurr nonsmal cell lung cancer studi identifi gene associ nsclc recurr patient not receiv adjuv chemotherapi purpos recent clinic trial suggest improv surviv adjuv chemotherapi nonsmal cell lung cancer nsclc studi identifi gene associ nsclc recurr patient not receiv adjuv chemotherapi experiment bank nsclc tumor patient underw resect stage iaiiib diseas identifi patient stratifi group recurr nonrecurr nr year after surgeri microarray cox multivari analysi perform conclus increas cypa gene express correl nsclc recurr promot prolifer through mechan involv part cypa epoxygenas activ experi comparison gene express recurr nonrecurr cancer homo sapien
transcript human cell line tissu luscomb reanalysi gnfnovarti data  express data util analysi deriv raw data publish su et al also known gnfnovarti dataset eafmx arrayexpress gse gds geo data contain differ human tissu cell type replic per tissuecel type data reprocess gcrma panp packag bioconductor fetus adult pituitari gland lymph node prefront cortex trigemin ganglion appendix tumor tongu olfactori bulb pon thyroid gland liver salivari gland tempor lobe tonsil superior cervic ganglion testi seminifer tubul subthalam nucleus pariet lobe adren gland trachea brain spinal cord adren cortex hypothalamus placenta amygdala ciliari ganglion dorsal root ganglion adipos tissu ovari cerebellum thalamus uterus bone marrow whole blood kidney smooth muscl pancrea whole brain globus pallidus cerebellum peduncl skelet muscl skin heart caudat nucleus medulla oblongata occipit lobe prostat lung uterus corpus cingul cortex testi thymus testi interstiti mixedsex femal male birth fecund cd cd cell cd endotheli bdca dentrit cell cd earli erythroid cardiac myocyt testi germ cell testi leydig cell adipocyt cd cell cd myeloid cd monocyt cd cell neg sel bronchial epitheli cd nk cell lymphoblast frozensampl white blood cell white blood cell clonet lot clonet cat cc ucsd clinom bioscienc inc gino van heek novarti cell line nhbe novarti graem bilb jose crespo clontech zenbio lot mt sinai allcel clinom am biotechnolog kavatha bach demar gamma rayinduc loss express hla glyoxalas allel lymphoblastoid cell proc natl acad sci homo sapien caucasian asian hispan year week tylenol aspirin elavil trauma ativan aspirin tylenol vioxx unk spontan abort xanax aspirin inderol sudden death chronic myelogen leukemia promyelocyt leukemia hl raji burkitt lymphoma lymphoblast leukemia molt colorect adenocarcinoma daudi burkitt lymphoma
transcript human left ventricular apex sampl  pair human left ventricular apex sampl harvest time implant left ventricular assist devic pre time explant post cohort includ patient clinic classifi ischem show evid coronari arteri diseas nonischem no evid coronari arteri diseas acut myocardi infarct im myocardi infarct within day implant tissu process hybrid affymetrix hgua chip cardiac ventricl homo sapien im im im im im im nonischem acut myocardi infarct ischem
transcript human mesenchym some possibl neural crest deriv neoplasm comparison mesenchym some possibl neural crest deriv neoplasm adult rightleg rightthigh spineofscapula rightbuttock rightelbow rightforearm lefttibia brachialplexus righthumerus leftdeltoid abdomin rightfemur leftforearm tvertebra groin leftleg distalrightfemur righttibia peronealnerv leftthigh leftfemur leftfibula leftkne rightshould proximalepiphysisofrighthumerus extracrani rightupperarm righttrapezius ribcag rightaxilla chestwal iliacfossa rayoffoot leftcalf skin rightulnarnerv rightkne leftfoot rightlatissimusdorsi tvertebra rightcalf tibia lowerback proximalepiphysisofrightfibula proximalepiphysisoflefttibia leftposteriortriangleofneck duramat sacrum hermaphrodit unknownsex femal male biopsi frozensampl homo sapien year lipoma chondrosarcoma monophas synovi sarcoma fibromatosi chondromyxoid fibroma embryon rhabdomyosarcoma schwannoma myxoid liposarcoma welldifferenti liposarcoma osteosarcoma chondroblastoma ewe sarcoma dedifferenti chondrosarcoma chordoma neurofibroma leiomyosarcoma sarcoma malign peripher nerv sheath tumor alveolar rhabdomyosarcoma
transcript human lung adenocarcinoma nontumor former current never smoke individu tobacco smoke respons over lung cancer case precis molecular alter induc smoke lung develop cancer impact surviv have remain obscur perform gene express analysi hgua affymetrix chip fresh frozen tissu sampl adenocarcinoma pair noninvolv lung tissu current former never smoker biochem valid smoke inform anova analysi adjust potenti confound multipl test procedur gene enrich analysi gofunct classif conduct gene select result confirm independ adenocarcinoma nontumor tissu studi identifi gene express signatur characterist smoke includ cell cycl gene particular those involv mitot spindl format eg nek ttk prc express these gene strong differenti both smoker nonsmok lung tumor earli stage tumor tissu nontumor tissu foldchange comparison consist import role pathway lung carcinogenesi induc smoke these chang persist mani year after smoke cessat nek ttk express noninvolv lung tissu also associ fold increas risk mortal lung adenocarcinoma smoker work provid insight smokingrel mechan lung neoplasia show veri mitot gene known involv cancer develop induc smoke affect surviv these gene candid target chemoprevent treatment lung cancer smoker experi adenocarcinoma nontumor tissu sampl select analys includ duplic triplic sampl subject qualiti control origin sampl provid suffici quantiti highqual rna microarray analys addit sampl exclud becaus problemat assay normal conduct remain microarray after normal sampl exclud becaus low percentag tumor cell tumor tissu report base sampl duplic averag result final express valu tumor nontumor tissu never smoker former smoker current smoker homo sapien
transcript human cervic cancer primari tumor cell line normal cervic epithelium  studi identif gene express cervic cancer role specif gene cervic carcinogenesi experi total sampl includ studi includ primari tumor cell line normal cervic epithelium homo sapien
transcript ovarian cancer generat prognost index ovarian carcinoma highest mortal rate among gynecolog malign project investig hypothesi molecular marker abl predict outcom ovarian cancer independ classic clinic predictor these molecular marker valid independ data appli semisupervis method predict patient surviv microarray cohort ovarian carcinoma toc cohort develop predict model then evalu entir independ cohort carcinoma duke cohort gene ovarian prognost index opi generat valid leaveoneout approach toc cohort kaplanmei analysi second valid step prognost power opi confirm independ data duke cohort multivari analysi opi independ postop residu tumour main clinicopatholog prognost paramet adjust hazard ratio toc cohort ci duke cohort ci construct combin score molecular data opi clinic paramet residu tumour abl defin patient group high signific differ surviv integr analysi gene express data well residu tumour optimis assess prognosi tradit treatment option limit analysi abl optimis clinic manag identifi those patient would candid new therapeut strategi experi rna frozen ovarian cancer sampl analys oligonucleotid microarray homo sapien
transcript human diffus larg bcell lymphoma dlbcl patient diffus larg bcell lymphoma dlbcl strike clinic molecular variabl although more precis identif multipl determin variabl still under investig there consensus highclinicalrisk dlbcl case requir riskadapt therapi sinc intensif chemotherapi autolog stemcel transplant asct been shown improv prognosi highrisk patient randomis clinic trial spite protocol these patient have high morbid associ asct multipl drug make import identifi patient take benefit riskadapt therapi through recognit biolog marker provid inform about both tumor cell microenviron unfortun mani studi so far perform have reli heterogen seri patient stage treat differ protocol instanc some variabl dlbcl aris fact diagnosi appli de novo secondari tumour nodal extranod irrespect clinic stage patient age associ infect addit dlbcl includ some specif variant such mediastin dlbcl thrbcl specif prognost paramet could prevent identif potenti predict biomark becaus result mani studi show search predict biomark should promot context sampl clinic homogen patient enrol clinic trial further sourc variabl depend some predict marker specif therapeut approach case bcl express dlbcl sinc bcl case have been shown not benefit addit chop have analys seri highclinicalrisk dlbcls twostag approach first identifi function signatur express analysi then analys surrog biomark tissu microarray tmas eclect approach could reveal new aspect relationship between neoplast cell microenviron lead identif previous unknown prognost marker same time function signatur analys expressionprofil data avoid poor reproduc data obtain genebygen analysi benefit exist grow bodi data concern major pathway deregul dlbcl avoid bias semiquantit score studi have quantifi marker includ multivari analysi experi patient experi studi perform seri highclinicalrisk dlbcl patient includ prospect trial geltamo spanish group grupo espa ol de linfoma trasplant de dula sea between june june high risk defin have either ageadjust ipi score ipi high microglobulin level experi all patient receiv therapi megachop after patient again evalu respons ct ga patient ct respons negat ga receiv anoth megachop cycl follow beam asct those patient posit ga without ct respons underw salvag treatment ifosfamid etoposid ife cours follow beam asct whenev respons been achiev june rituximab ad schema befor administ asct those patient less than partial respons pr progress diseas after ife remov studi experi diagnos revis panel pathologist follow world health organ criteria onli primari dlbcls includ analysi tcellhistiocyterich larg bcell lymphoma thrlbcls mediastin dlbcls exclud experi patient includ biolog analysi consecut select onli basi avail formalinfix paraffinembed frozen tissu repres tumour diagnosi final number case analys frozen diagnost tissu avail subset ten these patient experi inform consent obtain patient includ trial under supervis local ethic committe experi identifi biolog function surrog marker clinic predict experi express initi analys ten sampl frozen tissu avail these includ four patient die after treatment failur aliv complet remiss free diseas experi all frozen tissu correspond repres area tumour more than viabl tumor cell present experi multistep genesetenrich approach identifi function pathway deregul dlbcls resist treatment strategi experi analysi follow detail procedur includ supplementari inform materi method experi microarray analysi both cdna oligonucleotid microarray frozen diagnost sampl experi identif biolog function repres differenti express gene gene ontolog databas httpbioinformaticsweizmannacilcard experi select surrog immunohistochem marker repres biolog function identifi experi immunohistochem studi tissu microarray contain diagnost initi biopsi tissu patient experi semiquantit score experi quantif most relev marker experi identif biolog marker predict treatment respons experi relat between semiquantit measur protein evalu clinic outcom analys clinic endpoint cr after megachop cr after ife absenc progress after consolid hdt asct experi chisquar statist assess associ between proteinexpress level intermedi step treatment signific relationship nonsignific trend identifi experi failur defin progress death attribut tumour failurefre surviv ffs curv plot kaplanmei method statist signific associ between individu variabl ffs determin logrank test signific relationship nonsignific trend identifi experi gene cluster basi their biolog similar experi accumul altern marker alter analys chisquar spearman correl test onli signific relationship consid further experi surrog marker alter main cellular function select these marker consid order develop multivari logist regress model predict failur treatment protein found potenti inform analysi automat score experi various multivari model fit stepup forward stepdown backward variabl select other heurist procedur compar fit these model final predict logist regress model obtain final model estim odd ratio confid interv ci signific variabl general applic model test leaveoneout crossvalid differ predictor model found leaveoneout cross valid these show onli small variat weight marker accuraci also test receiv oper characterist roc curv estim discrimin abil model fit final model assess hosmerlemeshow test experi demonstr predict capac model patient rank accord score then divid quartil experi statist analys perform spss tool homo sapien
transcript human ovarian tumor normal ovari  individu ovarian tumor endometrioid serous mucin clear cell carcinoma individu normal ovari sampl assay affymetrix hgua array experi individu ovarian tumor endometrioid serous mucin clear cell carcinoma individu normal ovari sampl rna express analyz affymetrix hgua array per sampl homo sapien
transcript human pancrea patient autoimmun pancreat alcoholinduc chronic pancreat autoimmun pancreat aip recent identifi diseas pancrea unknown etiolog antigen studi determin new target antigen differenti regul gene protein mean transcriptom proteom valid them patient autoimmun pancreat report distinct downregul rna protein level pancreat proteas anion trypsinogen cation trypsinogen mesotrypsinogen elastas iiib pancreat stone protein autoimmun pancreat comparison alcoholinduc chronic pancreat pancrea femal male frozensampl homo sapien year autoimmun pancreat alcohol chronic pancreat
transcript cell line produc premalign tumor induc sensenc oncogeneinduc senesc cellular respons crucial protect against cancer develop investig so far been restrict cultur cell have been manipul overexpress oncogen analys tumour initi endogen oncogen ras show senesc cell exist premalign tumour not malign senesc therefor defin featur premalign tumour could prove valuabl diagnosi prognosi cancer homo sapien itmee itmeest itm itmst itv senesc bypass refer senesc induc
transcript human skin biposi lesion uninvolv psoriasi patient biopsi uninvolv lesion skin patient plaquetyp psoriasi base pair sampl gene more than fold differenti express lesion skin experi compar rna express uninvolv lesion skin patient mild sever plaquetyp psoriasi year year year year year year year year year year skin femal male homo sapien patient patient patient patient patient patient patient patient patient patient patient patient patient durat psoriasi year bodi surfac area percent erythema moder indur moder scale mild durat psoriasi year bodi surfac area percent erythema moder indur moder scale moder durat psoriasi year bodi surfac area percent erythema mild indur mild scale mild durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema mild indur mild scale mild durat psoriasi year bodi surfac area percent erythema mild indur moder scale mild durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema moder indur moder scale moder durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema mild indur mild scale minim durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema moder indur mild scale moder durat psoriasi year bodi surfac area percent erythema moder indur sever scale moder durat psoriasi year bodi surfac area percent erythema moder indur moder scale mild durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema mild indur minim scale mild durat psoriasi year bodi surfac area percent erythema sever indur moder scale mild durat psoriasi year bodi surfac area percent erythema moder indur mild scale moder durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear durat psoriasi year bodi surfac area percent erythema clear indur clear scale clear psoriasi uninvolv biopsi psoriat lesion biopsi
transcript human advanc bladder cancer predict respons surviv follow chemotherapi patient background cisplatincontain chemotherapi standard care patient local advanc metastat transit cell carcinoma urothelium respons rate around tumor deriv molecular prognost marker need estim respons surviv method affymetrix genechip express carri out tumor materi patient gene have express high correl surviv time after chemotherapi identifi these gene select valid immunohistochemistri ihc tumor tissu cisplatin treat patient have complet followup data result fiftyf differenti express gene correl signific surviv time these emmprin survivin valid ihc multivari analysi identifi emmprin express hazard ratio survivin express hazard ratio independ prognost marker poor outcom togeth presenc viscer metastas hazard ratio good prognosi group patient without viscer metastas both marker show signific discrimin power supplement risk factor within group patient subgroup patient no posit posit posit ihc stain emmprin survivin estim year surviv rate se respect respons chemotherapi could also predict oddsratio emmprin survivin respect conclus emmprin survivin protein identifi strong independ prognost predictor respons surviv after cisplatincontain chemotherapi patient bladder cancer experi tumor patient advanc bladder cancer studi sam analysi identifi gene covari treatment respons homo sapien
transcript human anaplast larg cell lymphoma alcl alcl cell line investig differ between tumor expressingnotexpress anaplast lymphoma kinkas affymetrix uua gene express data seri case system anaplast larg cell lymphomabr alcl alcl cell line confirm tumor express anaplast lymphoma kinas alk alcl alk alcl differ entiti identifi most signific differenti express gene between alk alk sampl generat molecular signatur alk alcl perform unsupervis analysi classifi alcl subgroup relat morpholog clinic variabl eg diseas stage enrich earli relaps patientsbr br princip investig dr georg delsol centr de physiopathologi toulousepurpan chupurpan toulous franc email delsolgchutoulousefr br programm cart didentit des tumeur cit ligu national contr le cancer lnccbr submitt fabien petel petelfliguecancernet pleural effus skin soft tissu lymph node peripher blood bone marrow femal male birth type cytotoxicassoci antigen perforin prf result negat type cd result posit type perivascular pattern result negat type cd result not determin type cytotoxicassoci antigen perforin prf result posit type cd result posit type cd result not determin type cytotoxicassoci antigen granzym gzmb result posit type perivascular pattern result posit type cytotoxicassoci antigen perforin prf result not determin type alk antibodi result posit type cytotoxicassoci antigen granzym gzmb result not determin type cd result negat type cd result posit type cd result negat type cd result not determin type cd result negat type cd result not determin type cd result posit cell homo sapien year small cell morpholog mix type morpholog common type morpholog anaplast larg cell lymphoma diseasestag not determin anaplast larg cell lymphoma diseasestag iv anaplast larg cell lymphoma diseasestag anaplast larg cell lymphoma anaplast larg cell lymphoma diseasestag anaplast larg cell lymphoma diseasestag 
transcript human colorect carcinoma patient express either high low level human guanyl bind protein gbp identifi coregul gene  gene express human colorect carcinoma patient either express high low level human guanyl bind protein gbp compar order identifi coregul gene adult colorect frozensampl homo sapien rc rc rc rc rc rc rc rc rc rc rc rc rc rc rc rc rc carcinoma
transcript human primari liposarcoma cultur reveal heterogen vitro effect doxorubicin doxorubicin consid most potent establish chemotherapeut treatment liposarcoma howev respons rate usual below still disappoint studi perform identifi gene express chang liposarcoma after doxorubicin treatment cell primari human liposarcoma harvest intraop brought cell cultur cell incub doxorubicin rna isol differenti gene express analys microarray techniqu microarray detail global gene express chang follow doxorubicin treatment primari liposarcoma cell cultur experi compar untreat primari cell cultur obtain liposarcoma treat doxorubicin treat cultur determin global gene express chang microarray analysi homo sapien
transcript fresh isol cd vs fresh isol cd adiposederiv adult stem cell adasc  order assess whether there differ gene express between polyclon cd polyclon cd cell popul adiposederiv adult stem cell adasc want identifi possibl gene differenti express between these cell popul end rna isol polyclon cd polyclon cd adasc differ donor analyz affymetrix microarray hgua then affymetrix program mas perform comparison could identifi differenti express transcript common between donor affymetrix program dmt adult adipos tissu abdomen adipos tissu abdomen thigh femal adiposederiv adult stem cell adasc freshsampl homo sapien donor donor donor fresh isol noncultur nc polyclon cd adasc fresh isol noncultur nc polyclon cd adasc year normal
transcript human oral sqamous cell carcinoma patient vs normal sampl associ gene express tumor invas there limit studi attempt correl express chang oral squamous cell carcinoma clinic relev variabl determin gene express tumor normal tissu patient mean affymetrix hua genechip hybrid rna isol cell obtain laser captur microdissect then amplifi label polymerasebas vitro transcript express gene found differ signific upregul downregul normal versus tumor tissu under independ statist method express chang four select gene lgals mmp lagi krt confirm revers transcriptas polymeras chain reaction twodimension hierarch cluster gene result sampl cluster accord extent tumor infiltr normal epitheli tissu tumor less than equal cm dimens tumor more than cm dimens same pattern cluster also observ downregul gene not observ ani associ lymph node metastasi experi perform microarray analysi rna oscc cell obtain lcm patient compar these result control squamous cell epithelium samplesw identifi express differenti express gene between normal tumor tissu found tumor invas tumor high correl gene express year year year year year year year year year year yeat year year year year femal male mandibl maxilla floor mouth tongu vestibul floor mouth homo sapien oscet oscet oscet oscet oscet oscet oscen oscet oscet oscet oscet oscen oscet oscet oscet oscet oscet oscet oscen oscen tnbm tnm tnm tnm tnm stage not applic tnm tnm tnbm tnbm oral squamous cell carcinoma normal sampl
transcript human uterin fibroid mith mutat wild type fumar hydratas gene  seri gene express measur uterin fibroid mutat wildtyp fumar hydratas fh gene uterus wildtyp mutant fumar hydratas homo sapien uterin corpus leiomyoma
transcript human diaphragm chronic obstruct pulmonari diseas copd patient vs control studi diaphragm muscl fast slow adapt transform diaphragm muscl chronic obstruct pulmonari diseas copd patient undergo adapt fast slow transform includ cellular adapt project studi signal mechan respons transform diaphragm muscl homo sapien refer chronic obstruct pulmonari diseas
transcript human chondrocyt antirheumat drug respons potenti molecular target stimul cartilag regener rheumatoid arthriti ra lead progress destruct articular structur despit recent progress control inflamm pain littl cartilag repair been observ vitro studi determin role chondrocyt rarel cartilag destruct antirheumat drugrel regen process human chondrocyt threedimension cultur algin bead determin rainduc gene express pattern human chondrocyt stimul supernat ra synovi fibroblast rasf normal donor synovi fibroblast ndsf respect examin antirheumat drug respons signatur human chondrocyt stimul supernat rasf have been treat diseasemodifi antirheumat drug dmard azathioprin sodium aurothiomal chloroquin phosphat methotrex nonsteroid antiinflammatori drug nsaid piroxicam diclofenac steroid antiinflammatori drug said methylprednisolon prednisolon genomewid express oligonucleotid microarray determin differenti express gene realtim rtpcr elisa perform valid microarray data follow antirheumat treatment microarray analysi disclos revert express rainduc chondrocyt gene involv inflammationnf signal cytokinechemokin activ immun respons proliferationdifferenti matrix remodel hierarch cluster analysi show treatment rasf dmard azathioprin gold sodium thiomal methotrex result chondrocyt gene express signatur close relat healthi pattern treatment said methylprednisolon prednisolon strong revert rarel chondrocyt gene express particular express gene involv inflammationnf cytokinechemokin activ nsaid piroxicam diclofenac dmard chloroquin phosphat onli moder margin effect pathway analysi determin major mechan drug action exampl pathway cytokinecytokin receptor interact tgf tlrjakstat signal ecmreceptor interact target vitro studi provid comprehens molecular insight antirheumat drug respons signatur human chondrocyt therebi reveal potenti molecular target pathway mechan drug action involv chondrocyt regener thus present studi contribut develop novel therapeut chondroprotect compound strategi experi drugrel suppress gene express activ chondrocyt determin genomewid microarray analysi chondrocyt stimul supernat rasf ndsf effect treatment dmard nsaid glucocorticoid test treat rasf prior collect supernat rna pool analyz group rasfstimul ndsf stimul rasftreat pool consist equal amount rna differ donor homo sapien
transcript human quadricep muscl young duchenn muscular dystrophi patient age match control albeit increas serum ck level abnorm muscl histolog alway present boy dmd phenotip indistinguish normal birth their first year life acquir earli motor mileston normal time clear defect muscl function becom general appar end second year diseas typic diagnos between age first year often consid refer clinic presymptomat defin gene express signatur shown character these symptomat patient sought investig whether extent alter also present muscl presymptomat dmd infant affymetrix technolog compar individu express dmd patient age biopsi scatter along first year diseas those age match control approach allow us describ high resolut alter transcript state character earli presymptomat phase diseas highlight some molecular pathway potenti critic target pathophysiolog diseas experi subject experi relev data about particip post under supplementari materi tabl st all dmd patient diagnosi duchenn muscular dystrophi base absenc dystrophin immunoreact quadricep muscl section none particip time biopsi been under corticosteroid treatment control biopsi select diagnost specimen not given diagnosi neuromuscular diseas nor show ani nonspecif myopath sign miam compliant descript studi post under supplementari materi miam complianc experi rna extract experi total rna extract frozen quadricep muscl biopsi trizol trizol reagent invitrogen rna further purifi rnaeasi mini kit follow rna cleanup protocol indic manufactur qiagen rna puriti integr assess spectophotometr analysi agaros gel electrophoresi experi affymetrix genechip experi work made chip type affymetrix hgua genechipcrna synthesi perform ug total rna templat describ affymetrix gene express manual genechip wash stain affymetrix fluidic station avoid overcorrel sampl process time arrang have both dmd control sampl experiment session homo sapien
transcript mous pooh cell line poufoct overexpress human pouf more common known oct stem cell marker affect direct differenti embryon stem cell investig whether cell mesenchym origin acquir embryon phenotyp generat human cell line mesoderm origin overexpress chimer pouf gene physiolog coactiv ew driven potent ew promot transloc cell line term pooh poufoct overexpress human cell express embryon stem cell gene such nanog also nontransloc pouf lost mesenchym phenotyp exhibit embryon stem celllik alveolar structur implant subcutan tissu immunodefici mice hierarch analysi microchip analysi cell surfac analysi reveal pooh cell subcategor group human embryon stem cell embryon carcinoma cell these result impli cell mesenchym origin partial trace back cell embryon phenotyp pouf gene collabor potent cisregulatori element fuse coactiv experi pooh cell generat primari first passag cell pelvic tumor yamaguchi et al gene chromosom cancer jun cultur tissu cultur dish mm becton dickinson medium med shirotori tokyo all cultur maintain humidifi atmospher contain air co homo sapien
transcript human normal neuroblast vs malign neuroblastoma low highstag comparison normal neuroblast malign neuroblastoma low highstag embryo adren gland abdomen femal male neuroblastoma adren neuroblast adren cortex cell frozensampl homo sapien case neuroblast nb cortex case neuroblast neuroblast case cortex case cortex abort social reason therapeut abort becaus trisomi spontan abort unknown reason highstag neuroblastoma normal lowstag neuroblastoma
transcript human cultur chrondrocyt treat supernat synovi fibroblast ra patient vs control investig key regulatori molecul cartilag destruct rheumatoid arthriti  have studi express cultur human chondrocyt stimul supernat synovi fibroblast deriv ra patient rasfhs cell line normal donor ndsfkim cell line respect purpos passag human chondrocyt cultur day algin bead subsequ stimul hour supernat rasf ndsf baselin express determin unstimul chondrocyt differenti genomewid microarray analysi rasf ndsf stimul chondrocyt disclos distinct express relat cartilag destruct involv marker gene inflamm cox nfkappa signal pathway tlr cytokineschemokin receptor cxcl ccl cxcl cxcr il ilbeta matrix degrad mmp mmp suppress matrix synthesi comp thus transcriptom rasf ndsf stimul chondrocyt reveal disturb catabolicanabol homeostasi chondrocyt function studi provid comprehens insight molecular regulatori process induc human chondrocyt dure rarel cartilag destruct experi reveal rarel chondrocyt gene express genomewid microarray analysi rasf stimul human chondrocyt compar ndsf stimul perform unstimul chondrocyt analyz baselin gene express microarray analysi rasf ndsf stimul unstimul chondrocyt respect rna pool analyz pool consist equal amount rna differ donor homo sapien
transcript human prostat cancer cell line normal prostat epitheli stromal cell primari cultur  primari goal studi assess differ gene express between prostat cancer cell line normal prostat epitheli stromal cell primari cultur experi sampl analyz replic sampl includ prostat cancer cell line normal prostat epitheli cell system primari cultur normal prostat stromal cell system primari cultur homo sapien
transcript human preinvas invas cervic squamous cell carcinoma normal cervic epithelia  normal squamous cervic epitheilia sampl high grade squamous intraepitheli lesion invas squamous cell carcinoma cervix sampl obtain laser captur miicrodissect round tbase linear rna amplif arcturus riboamp kit perform sampl assay affymetrix hgua array experi normal squamous cervic epitheilia sampl high grade squamous intraepitheli lesion invas squamous cell carcinoma cervix differ patient assay singl hgua array addit test sampl also assay experi logtransform probeset valu result statist analysi probeset associ readm file includ supplementari file homo sapien
transcript oligo array neuroblastoma display loss chromosom  gene express analysi primari neuroblastoma tumor cell line cervico thorac thorac abdomin thoracoabdomin pelvic biopsi freshsampl european collect cell cultur httpwwwecaccorguk homo sapien case case case case case case case case case case case case case case case case case case case case case case case case sknas kelli stage stage stage stage stage stage ganglioneuroblastoma ganglioneuroma ganglioneuroblastoma intermix neuroblastomadifferenti neuroblastomapoor differenti neuroblastomaundifferenti
transcript human muscl specimen hibm patient carri mt persian jewish founder mutat investig hereditari inclus bodi myopathi hibm hibm neuromuscular disord character adultonset slowli progress distal proxim muscl weak gene express measur muscl specimen hibm patient carri mt persian jewish founder mutat gne present mild histolog chang healthi match control individu experi sampl taken muscl specimen deltoid bicep quadricep tibiali hibm patient carri mt persian jewish founder mutat gne present mild histolog chang age patient rang between addit match sampl taken healthi control individu deltoid bicep quadricep gluteus paraspin tricep muscl age rang homo sapien
transcript human skelet muscl year old individu fed low high protein diet inadequ dietari protein intak caus advers chang morpholog function skelet muscl these chang reflect earli alter muscl mrna level microarray analysi assess whether inadequ protein intak differenti affect skelet muscl transcript level express older adult experi older male femal age consum control diet contain protein kg adequ protein wk then protein kg inadequ protein ip group second wk rna isol fastingst vastus laterali biopsi obtain end period transcript level determin affymetrix ua array homo sapien
transcript human glioblastoma pseudopalisad cell  compar common tumor cell gene differenci express pseudopalisad cell human glioblastoma common tumor cell pseudopalisad cell homo sapien glioblastoma
transcript human benign malign thyroid follicular neoplasi differenti between follicular thyroid carcinoma follicular thyroid adenoma base their genet signatur adult thyroid unknownsex femal thyroid follicular epitheli cell frozensampl homo sapien follicular thyroid carcinoma follicular thyroid adenoma
transcript human juvenil pilocyt astrocytoma reveal potenti subgroup juvenil pilocyt astrocytoma jpa most common brain tumor children express jpas determin affymetrix genechip ua compar subject normal cerebella gene involv neurogenesi cell adhes synapt transmiss central nervous system develop potassium ion transport protein dephosphoryl cell differenti found signific deregul jpa these jpas further cluster major group unsupervis hierarch cluster gene high covari supervis analysi signific analysi microarray softwar between these potenti subgroup identifi list signific differenti express gene involv cell adhes regul cell growth cell motil nerv ensheath angiogenesi immunostain myelin basic protein paraffin section deriv incomplet resect jpas suggest jpa without myelin basic protein posit stain tumor cell have higher tendenc progress experi under institut review board approv protocol brain tumor tissu obtain after inform consent patient undergo tumor resect other tumorrel neurosurg procedur texa children hospit baylor colleg medicin sampl normal cerebellar tissu isol surgic remov tissu adjac resect tumor tissu portion tumor fix formaldehyd embed paraffin section patholog review residu tissu sampl snapfrozen liquid nitrogen store rna extract all sampl obtain initi diagnosi no prior exposur chemotherapi radiat therapi normal fetal brain rna obtain stratagen la jolla ca normal cerebellum rna ambion inc austin tx total rna isol trizol reagent invitrogen carlsbad ca follow dnase treatment cleanup arneasi spin column qiagen valencia ca rna qualiti puriti assess agaros gel electrophoresi absorb measur aa homo sapien
transcript human trophoblast cell isol first trimest human placenta villous explant cultur invas cytotrophoblast uterin tissu essenti placent develop identifi molecul regul trophoblast invas mrna signatur purifi villous ctb poor invas extravil evt high invas trophoblast isol first trimest human placenta villous explant cultur respect compar genechip analys yield invasionmigr relat transcript sever gene involv physiolog patholog cell invas includ adam well spondin upregul evt pathway predict analys identifi sever function modul associ either invas noninvas trophoblast phenotyp gene downregul invas mrna pool heme oxygenase ho select function analys realtim pcr analys western blott immunofluorescen first trimest placenta differenti villous explant cultur demonstr downregul ho invas evt compar ctb modul ho express lossof well gainof function cell model bewo htrsvneo respect demonstr invers relationship ho express trophoblast migrat transwel wound heal assay import ho express led increas protein level activ nuclear hormon receptor ppargamma pharmacolog inhibit ppargamma abrog inhibitori effect ho trophoblast migrat collect result demonstr gene express evt ctb unravel novel regul cell invas accord identifi heme oxygenase negat regul trophoblast motil act upregul ppargamma experi identifi gene potenti regul cell invas trophoblast cell earli human gestat distinct invas properti experi distinct gene express signatur high invas evt poor invas ctb differ first trimest placenta affymetrix ua genechip interrog gene determin homo sapien
transcript human nephroblastoma  sampl tumor normal kidney nk fetal kidney fk cell line hybrid affymetrix hgua genechipstumor classif base character wt betacatenin identif major differ between categori wilm tumor defin accord wt ctnnb genom express featur first larg scale studi base postchemotherapi resect tumor accord siop protocol fetus left kidney right kidney kidney male femal frozensampl homo sapien ctnnb not mutat ctnnb mutat fk nk nk nkpool fk nk fk nk nk month unilater bilater aliv without relaps aliv relaps deceas stromal predomin blastem perilobar nephrogen rest normal wilm tumor
transcript cancer non cancer lung adenocarcinoma tissu tumour normal sampl human lung carcinoma patient plus tumour onli patient comparison gene express cancer non cancer lung adenocarcinoma tissu tumour normal sampl patient plus tumour onli patient lung femal male homo sapien year cancer non cancer
transcript human mesenchym precursor cell deriv embryon stem cell comparison express human undifferenti es cell mesenchym es cell bone marrow mesenchym stem cell embryon stem cell embryon stem cell deriv mesenchym stem cell homo sapien
transcript ebv transform fibroblast vs untransform analys dna replic time analysi human chromosom high resolut differ development state dna replic time analysi human chromosom high resolut differ development state lung femal primari embryon fibroblast human lymphoblastoid cell dsmz germani homo sapien ebv transform ccl ncnc
transcript hematopoiet adipos tissuederiv stem cell comparison gene express differ stem cell type hematopoiet adipos tissuederiv stem cell adult adipos tissu bone marrow adipos tissuederiv stem cell hematopoiet stem cell frozensampl homo sapien hsc donor hsc donor atmsc donor atmsc donor atmsc donor hsc donor normal
transcript human facioscapulohumer muscular dystrophi fshd muscl  facioscapulohumer muscular dystrophi fshd autosom domin disord link contract dz repeat array subtelomer region chromosom compar genomewid gene express data muscl biopsi patient fshd those other neuromuscular disord intend identifi diseasespecif chang more like involv earli stage diseas progress data will help identifi patholog mechan involv fshd experi comparison fshd other condit diseasespecif chang condit nhm normal healthi muscl jdm juvenil dermatomyos hsp human spastic paraplegia fshd facioscapulohumer dystrophi unaffect affect fkrp fukutin relat protein defici edl emerydreifuss muscular dystrophi lamin ac defici ede emerydreifuss muscular dystrophi emerin defici dysf dysferlinopathi dmd duchenn muscular dystrophi calp calpain defici bmd becker muscular dystrophi aqm acut quadripleg myopathi al amyotroph later sclerosi homo sapien
transcript human ewe sarcoma sampl ewsfli inhibit ewe sarcoma cell line  cellular origin ewe tumor et tumor bone soft tissu character specif fusion between ew et gene high debat through gene express analysi compar et varieti normal tissu show differ ewsflisilenc ewe cell line converg toward mesenchym stem cell msc moreov upon ewsfli silenc differ ewe cell line differenti along adipogen lineag incub appropri differenti cocktail addit ewe cell also differenti along osteogen lineag upon longterm inhibit ewsfli these silico experiment data strong suggest inhibit ewsfli allow ewe cell recov phenotyp their msc progenitor experi ewe tumor ewsfli inhibit cell line affymetrix ua gpl array homo sapien
transcript human uber sclerosi complex tsc tumor fibroblast patient tuber sclerosi complex tsc develop hamartoma contain biallel inactiv mutat either tsc tsc result mammalian target rapamycin mtor activ hamartoma overgrow epitheli mesenchym cell tsc skin pathogenet mechan these chang not been investig exist locat cell biallel mutat twohit cell result mtor activ unclear compar tsc skin hamartoma facial angiofibroma periungu fibroma normalappear skin same patient observ more prolifer mtor activ hamartoma epidermi twohit cell not detect epidermi fibroblastlik cell dermi howev exhibit allel delet tsc both touch prepar fresh tumor sampl cell grown tsc skin tumor suggest increas epiderm prolifer mtor activ not caus secondhit mutat keratinocyt mesenchymalepitheli interact gene express array identifi potenti paracrin factor releas mesenchym cell reveal more epiregulin mrna fibroblastlik angiofibroma periungu fibroma cell than fibroblast normalappear skin same patient elev epiregulin mrna confirm realtim pcr increas amount epiregulin protein demonstr immunoprecipit elisa epiregulin stimul keratinocyt prolifer phosphoryl ribosom protein vitro these result suggest hamartomat tsc skin tumor induc paracrin factor releas twohit cell dermi prolifer mtor activ over epidermi effect epiregulin experi studi casecontrol biolog replic tumor case normal control fibroblast cell isol four patient biolog replic homo sapien
gene express human osteosarcoma  pulmonari metastasi continu most common caus death osteosarcoma inde year surviv newli diagnos osteosarcoma patient not signific chang over year further understand mechan metastasi resist aggress pediatr cancer necessari pet dog natur develop osteosarcoma provid novel opportun model metastasi develop progress given acceler biolog canin osteosarcoma hypothes direct comparison canin pediatr osteosarcoma express help identifi novel metastasisassoci tumor target have been miss through studi human cancer alon collect these data support strong similar between human canin osteosarcoma underlin opportun provid compar oncolog approach mean improv understand cancer biolog therapi experi human osteosarcoma singl channel homo sapien
transcript human breast cancer cell line microarray detail global programm gene express under breast cancer cell line identifi main group luminaltyp basaltyp breast cancer cell line unsupervis pearson correl breast cancer cell line intrins subtyp supervis analysi spindl versus nonspindl breast cancer cell line identifi spindl cell signatur gene identifi all spindl basaltyp ecadherin methyl breast cancer cell line experi breast cancer cell line grown optim cell densiti rna extract hybrid affymetrix microarray homo sapien
rnai human ezh specif sirna treat cell reveal ezh mediat ewsfli driven tumor growth block endotheli neuroectoderm differenti ewe tumor et high malign tumor local bone soft tissu molecular defin ewset transloc identifi histon methyltransferas enhanc zest drosophila homolog ezh increas et ezh suppress activ maintain stem normal malign cell found ezh upregul pathognomon fusion oncogen ewsfli et mesenchym stem cell downregul ezh rna interfer et suppress oncogen transform inhibit clonogen vitro similar tumor develop metastasi immunodefici rag mice suppress ezhmedi gene silenc shown depend histon deacetylas hdac activ subsequ microarray analysi ezh knock down hdacinhibitor treatment confirm independ assay reveal undifferenti phenotyp maintain ezh et downregul ezh decreas histon lysin trimethyl hkme target loci ezh regul stem gene such nerv growth factor receptor ngfr well gene involv neuroectoderm differenti emp ephb gfap gap these data suggest ezh might play central role ewe tumor patholog shape oncogen stem cell phenotyp tumor presum epigenet regul experi cell treat hour either nm trichostatin tsa dmso sirna experi ezh specif sirna cell resuspend medium contain nm sirna transfect reagent incub hour rna cell under such treatment isol trizol subject microarray analysi onto human ua microarray follow affymetrix protocol homo sapien
transcript pterygium cornea gene express pterygium benign growth conjunctiva analysi conjunctiva pterygium sampl homo sapien
transcript popul nonhematopoet stem cell msc mapc isol human bone marrow compar behaviour popul nonhematopoet stem cell msc mapc isol human bone marrow effect cultur condit behaviour msc also characteris isol msc then cultur cell mapc growth condit fetus bone marrow mesenchym stem cell condit mesenchym stem cell fibroblast multipot adult progenitor cell freshsampl homo sapien cmsc msc msc cmsc mapc msc wi mapc mrc mapc cmsc mrc wi year
transcript endotheli cell dermal fibroblast treat antihcmv antibodi induc modif typic scleroderma phenotyp both human endotheli cell dermal fibroblast have been treat antihcmv antibodi induc modif typic scleroderma phenotyp adult connect tissu endothelium endotheli fibroblast freshsampl homo sapien
transcript human stem cell enrich hair follicl bulg cell  human hair follicl bulg import nich keratinocyt stem cell kscs elucid human bulg cell biolog could facilit analysi global gene express identif uniqu cellsurfac marker lack distinct bulg morpholog human hair follicl hamper studi bulg cell kscs studi determin distribut labelretain cell defin human anagen bulg navig laser captur microdissect bulg cell outer root sheath cell other follicl region obtain analyz cdna microarray gene transcript encod inhibitor wnt activinbon morphogen protein signal overrepres bulg while gene respons cell prolifer underrepres consist exist quiescent noncycl kscs anagen follicl posit marker bulg cell includ cd phlda follistatin frizzl homolog while cd cd cd cd preferenti express nonbulg keratinocyt import cd cell cdhicdlocdlocdlocdlo obtain hair follicl suspens demonstr high colonyform effici clonogen assay indic success enrich live human bulg stem cell stem cell behavior enrich bulg cell their util gene therapi hair regener will need assess vivo assay nonbulg outer root sheath region bulg outer root sheath region homo sapien
transcript human sampl identifi marker earli diagnosi endoprosthesi loosen  studi identifi marker earli diagnosi endoprosthesi loosen differenti between wearparticl induc septic loosen well gather new insight pathogenesi gene differenti express fold chang greater than among these chitinas cd calpain apolipoprotein cd lysyl oxidas cathepsin ecadherin vecadherin nidogen angiopoietin thrombospondin differenti express level valid rtpcr chitinas activ signific higher blood patient wearparticl induc prosthesi loosen howev chitinas activ marker earli diagnosi specif sensit onli due high variabl both diseas control group experi gene express generat periprosthet membran wearparticl induc infecti septic type affymetrix hg ua oligonucleotid microarray result select differenti express gene valid rtpcr enzym activ genotyp chitinase assess serum sampl consecut patient hospit endoprosthesi loosen other reason serv control subject homo sapien
transcript human skelet muscl obes vsnormal individu identifi mrna protein involv fat oxid reduc obes morbid obes individu  been found fat oxid reduc skelet muscl obes human studi identifi mrna protein involv fat oxid reduc obes morbid obes individu inform gather will help understand obes contribut cardiovascular diseas insulin resist sampl obtain patient undergo elect abdomin surgeri skelet muscl homo sapien nonobes morbid obes obes
transcript mous scid after intestin xenotranspl infect shigella  analys transcriptom respons human intestin tissu engraft scid mice shigella infect experi four experiment condit biolog replic experi after hour infect tissu remov arn extract befor label hybrid ua genechip homo sapien
transcript human embryon stem cell hesc deriv mesenchym precursor cell popul  have develop effici protocol deriv mesenchym precursor hesc while previous protocol base mesoderm induct cocultur hesc op mous stroma barberi et al plos biolog recent work show deriv hesc deriv mesenchym precuror under feederfre condit data present show larg high signfic overlap global gene express between hesc deriv mesenchym precursor deriv under feederfre condit those deriv op coculur mesenchym precurosr isol direct adult bone marrow experi these data compar gene express hesc deriv mesenchym precursor deriv op protocol those obtain under feederfre condit adult bone marrow deriv mesenchym precursor sampl undifferenti hesc subtract gene defin mesenchym precurosr cell specif signatur barberi et al natur medicin detail homo sapien
transcript cancer cell line differ origin gene express cancer cell line breast lung pancreat gasctric ovarian hepatocellular prostat carcinoma melanoma experi cell harvest after seed rna isol perform usign qiagen rneasi kit hybridis perform affymetrix protocol no replic measur perform homo sapien
transcript human breast cancer metastasi brain identifi gene involv brain metastasi most fear complic cancer most common intracrani malign adult under mechan remain unknown breast cancer patient metastat diseas isol cell popul aggress colon brain transcriptom analysi these cell yield overlap gene whose express select associ brain metastasi express seventeen these gene primari breast tumor associ brain relaps breast cancer patient some these gene also associ metastasi lung not liver bone lymph node provid molecular basi longobserv clinic link between brain lung metastasi among function valid brain metastasi gene cyclooxygenas cox egfr ligand hbegf brainspecif sialyltransferas stgalnac mediat cancer cell passag through bloodbrain barrier other brain metastasi gene encod inflammatori factor brainspecif proteolyt regul suggest multifacet program breast cancer colon brain experi differ breast cancer cell line mdamb fresh isol pleural effus cn studi mdamb group contain biolog replic parent unselect popul brain metastat isol cn contain biolog replic parent unselect popul brain metastat isol case parent popul compar brain metastat isol identifi gene express chang associ brain metastat phenotyp homo sapien
transcript muscl hypopituitari men befor after growth hormon treatment investig effect growth hormon metabol process muscl muscl target growth hormon gh action major contributor whole bodi metabol littl known about gh regul metabol process muscl extent muscl contribut chang whole bodi substrat metabol dure gh treatment identifi ghrespons gene regul substrat metabol muscl studi hypopituitari men underw whole bodi metabol measur muscl biopsi befor after week gh treatment mgday transcript four subject analys affymetrix genechip serum insulinlik growth factor igfi procollagen measur ria gh increas serum igfi procollagen enhanc whole bodi lipid oxid reduc carbohydr oxid stimul protein synthesi induc gene express igfi collagen muscl gh reduc express sever enzym regul lipid oxid energi product reduc calpain increas ribosom protein express display mix effect gene encod myofibrillar protein increas express circadian gene clock reduc period summari gh exert concord effect muscl express blood level igfi collagen induc chang gene regul protein metabol parallel whole bodi anabol effect discord between muscl gene express metabol respons suggest muscl unlik contribut ghinduc stimul whole bodi energi lipid metabol gh regul circadian function muscl modul circadian gene express possibl metabol consequ adult muscl male homo sapien cc jm fb cw hypopituitar
transcript cdcd stem cell more differenti cdcd progenitor cell gene express cdcd stem cell more differenti cdcd progenitor cell compar comparison express hematopoiet stem cell fetal liver umbil cord blood bone marrow mobil pheripher blood allow us identifi uniqu gene conserv express dure ontogeni experi cdcd en cdcd cell popul isol cell sort human bone marrow mobil peripher blood umbil cord blood fetal liver total rna isol cell popul follow synthesi biotinyl crna after fragment biotinyl crna hybrid affymetrix ua chip homo sapien
transcript human acut lymphoblast leukemia sampl diagnost purpos  studi cohort highrisk pediatr bprogenitor all patient exclud known high risk all subtyp bcrabl infant all affymetrix singl nucleotid polymorph microarray gene express candid gene resequenc cna poor outcom predictor identifi semisupervis princip compon approach test independ valid cohort pediatr bprogenitor all case over region recur somat acquir cna most frequent target gene encod regul blymphoid develop case pax target ikzf cna classifi identifi veri poor outcom subgroup highrisk cohort px strong associ presenc delet involv ikzf encod earli lymphoid transcript factor ikaro classifi ikzf delet also predict poor outcom elev minim residu diseas end induct therapi valid cohort gene express signatur poor outcom group character reduc express lineag specif gene high relat express signatur bcrabl all known highrisk all subtyp also character high frequenc ikzf deletionsomat acquir delet involv ikzf identifi veri poor outcom subgroup pediatr all patient incorpor molecular test identifi ikzf delet diagnost leukem blast should improv abil accur risk stratifi patient appropri therapi affymetrix ua array perform accord maufactur direct rna extract cryopreserv diagnost bone marrow peripher blood sampl sampl less than blast flow sort prior rna extract experi hundr seventi five pediatr bprogenitor all sampl studi either affymetrix ua homo sapien
transcript human muscl biopsi pretreat dermatomyost patient vs normal control defin molecular pathway muscl myositi patient idiopath inflammatori myopathi polymyos dermatomyos heterogen group muscl disord unknown etiologyth pathogen pathway respons muscl fiber damag dysfunct myositi not current well defin identif such pathway help novel therapeut intervent also help develop diagnost test experi muscl biopsi separ group adult untreat femal dm patient compar muscl tissu normal human healthi volunt defin molecular pathway muscl myositi patient confirm map key pathway member specif cell type muscl tissu patient control rtpcr western blot immunoloc skelet muscl femal unknown biopsi frozensampl homo sapien normal dermatomyos
transcript human male vastus laterali muscl sampl healthi copd subject befor after month train needl biopsi obtain vastus laterali muscl healthi sedentari yearold male befor after month train vastus laterali male homo sapien individu individu individu individu individu individu individu individu individu individu individu individu year normal chronic obstruct pulmonari diseas
transcript excision biopsi wound young old human subject measur influenc age cutan wound heal  experi measur influenc age cutan wound heal human subject incread age been associ delay wound heal mous model human gene express compar between excision biopsi wound young old subject adult skin male birth freshsampl homo sapien year wound tissu
transcript human oment adipos tissu women polycyst ovari syndrom pcos context polycyst ovari syndrom pcos frequent associ viscer obes suggest oment adipos tissu might play import role pathogenesi syndrom object object studi express oment fat biopsi sampl obtain morbid obes women without pcos time bariatr surgeri casecontrol studi conduct studi academ hospit patient eight pcos patient seven nonhyperandrogen women submit bariatr surgeri becaus morbid obes intervent biopsi sampl oment fat obtain dure bariatr surgeri main outcom measur main outcom measur highdens oligonucleotid array result after statist analysi identifi chang express pattern gene between pcos control sampl gene classif assess through data mine gene ontolog annot cluster analysi dysregul gene between both group these method highlight abnorm express gene encod certain compon sever biolog pathway relat insulin signal wnt signal oxid stress inflamm immun function lipid metabol well other gene previous relat pcos metabol syndrom conclus differ gene express viscer adipos tissu pcos patient compar nonhyperandrogen women involv multipl gene relat sever biolog pathway suggest involv abdomin obes pathogenesi pcos more ampl than previous thought not restrict induct insulin resist adipos tissu homo sapien refer normal polycyst ovari syndrom
transcript primari ovarian tumor depress nondepress patient gene express carri out primari ovarian carcinoma patient primari research question whether gene express differ tissu individu high vs low symptom psycholog depress experi gene express carri out primari ovarian carcinoma patient primari research question whether gene express differ tissu individu high vs low symptom psycholog depress homo sapien
transcript human wilm tumor sampl predict relaps favor histolog case  gene express pattern favor histolog wilm tumor fhwt relaps compar those not relaps oligonucleotid array descript fhwt all stage enrich relaps treat nation wilm tumor studi pass qualiti paramet suitabl analysi oligonucleotid array relaps risk stratif util support vector machin ten fold crossvalid appli number gene associ relaps less than predict chanc alon patient relaps stage fhwt no further analys perform number greater than expect chanc local stage patient cross valid includ addit local stage patient total patient relaps demonstr classifi relaps compos gene associ median sensit specif total error rate analysi gene differenti express relaps patient reveal apoptosi wnt signal igf pathway epigenet modif mechan import relaps potenti therapeut target includ frapmtor cd experi stage fhwt fiftythre relaps case ninetyon nonrelaps control minimum year followup includ all relaps random select nonrelaps frozen tumor tissu avail pass all qualiti control paramet nwts protocol approv review board institut regist patient histolog diagnosi local stage confirm central review experi qualiti control step taken experi sampl snap frozen immedi follow surgeri mail dri ice tumor bank retain experi frozen section evalu histolog tumor less than viabl tumor cellular exclud experi array imag assess eye confirm scanner align absenc signific bubbl scratch experi sampl ratio gapdh greater than exclud experi biob spike control confirm present bioc biod cre confirm increas intens experi scale target intens scale factor between background level valu mean intens within accept limit experi rang percent present call experi verif gene express perform util quantit rtpcr five gene experi statist analysi positionaldependentnearestneighbor model pdnn softwar translat scan imag express analysi file normal data across all array httpodinmdacctmceduzhangliperfectmatch gene maximum express less than log scale across all tumor affymetrix control gene exclud result probe analysi support vector machin svm develop chang lin httpwwwcsientuedutwcjlinlibsvm implement softwar packag chosen relaps risk stratif pvalu ttest comparison between case control select gene all tumor gene identifi pvalu provid data tabl label ttest comparison between case control ie supplement tabl relat public ten fold cross valid util investig abil classifi establish random select train predict relaps independ test compris remain tumor twofold cross valid dataset random divid time train correspond test equal size includ half patient relaps classifi relaps identifi train assign tumor correspond test low high risk categori train test then swap number top gene classifi evalu rang therefor total differ classifi develop valu train tenfold cross valid dataset random divid time ten group approxim equal size group includ approxim same number relaps such group classifi built remain sampl then categor tumor group low high risk process repeat until all tumor sampl categor low high risk all cross valid procedur avoid geneselect bias classifi complet rebuilt cross valid iter homo sapien
transcript monkey bone marrowderiv mesenchym stem cell examin effect age  object studi elucid agerel differ gene express rhesus monkey bone marrowderiv mesenchym stem cell rhmsc obtain fetal infant adult donor relev their growth other properti although high degre similar observ rhmsc gene express compar age group signific differ found strong parallel gene express human msc potenti function relev differenti gene express most appar compar fetal adult rhmsc transcript observ gene express consist loss rhmsc pluripot prolif capac advanc donor age addit these data highlight import nonhuman primat model system studi properti human stem cell experi total eleven bone marrowderiv mesenchym stem cell cultur establish rhesus monkey divers age rang gestat day year old adult total rna harvest these cultur gene express analys conduct oligonucleotid microarray express subset gene confirm qrtpcr analysi detail manuscript detail result studi current under review macaca mulatta
transcript human airway smooth muscl cell after treatment glucocorticoid protein kinas  glucocorticoid gcs protein kinas pkaactiv agent betaadrenerg receptor agonist mainstream asthma therapi base their abil prevent revers excess airway smooth muscl asm constrict their abil regul anoth import featur asthma excess asm growth poor understood recent studi have suggest gcs render agent inflamm such interleukin beta tumor necrosi factor alpha mitogen asm suppress antimitogen induc cyclooxygenasedepend pka activ further explor mechanist basi these observ assess effect epiderm growth factor interleukin beta stimul modulatori effect gc treatment pka inhibit asm transcriptom microarray analysi experi human asm cultur generat trachea unidentifi donor passag these cell generat cell stabe express pka inhibitor pki gfp control then grown confluenc serum starv stimul ilb egfor both ei presenc absenc fluticason flu min pretreat after stimul cell wash total rna isol trizol per manufactur protocol gene express analyz differ cultur deriv differ donor total microarray per condit homo sapien
transcript human pituitari adenoma  seri includ four major subtyp pituitari adenoma normal postmortem pituitari tissu data transform affymetrix microarray suit global scale appli quantif data adjust averag record target intens data then export bioinformat softwar genespr silicon genet redwood citi ca further analysi data normal perform scale data so averag intens valu array divid express valu median express level chip individu gene express level pituitari adenoma subtyp array divid express level normal pituitari array thus data present relat express normal pituitari tissu filter then perform identifi gene overexpress underexpress least fold tumour compar normal pituitari tabl gene est differenti overexpress fold least pituitari adenoma subtyp compar normal pituitari negat valu repres underexpress where gene repres more than probe individu probe data given tabl gene est differenti underexpress fold least pituitari adenoma subtyp compar normal pituitari negat valu repres underexpress where gene repres more than probe individu probe data given homo sapien
transcript human primari acut lymphoblast leukemia cell bone marrow pediatr associ methotrex treatment respons genomewid assess gene express primari acut lymphoblast leukemia cell perform identifi genom determin mtx antileukem effect reduct circul leukemia cell after vivo methotrex treatment serv measur mtxs antileukem effect experi gene express diagnost primari acut lymphoblast leukemia cell bone marrow pediatr patient homo sapien
transcript bone marrow sampl human acut myeloid leukemia patient gene express acut myeloid leukemia bone marrow bm sampl adult patient newli de novo diagnos amlal sampl contain more than blast cell total rna extract trizol reagent life technolog gaithersburg md purifi rneasi mini kit quiagen valencia ca rna integr assess agil bioanalyz agil palo alto ca label rna then fragment hybridaz hua oligonucleotid array affymetrix santa clara ca contain probe accord affymetrix protocol array scan gene array scanner affymetrix adult bone marrow blast cell inv invers transloc homo sapien matur minim differenti without matur acut myelomonocyt leukemia acut promyelocyt leukemia acut erythroid leukemia acut monoblasticmonocyt leukemia acut myeloid leukemia
transcript human huvec cell infect candida  oligonucleotid microarray analysi identifi gene transcript upregul suppress upon exposur endotheli cell albican among regul gene those attribut categori chemotaxi signal transcript translat remark overrepres experi perform independ experi compar express untreat huvec monolay those candidainfect huvec monolay homo sapien
transcript hela cell transfect mectmamltarget identif downdown target gene differenti regul mectmaml oncoprotein compar transloc gene partner maml mect transfect freshsampl clontech homo sapien hela teton
transcript time seri gene express follow irradi identifi activ  purpos experi generat time cours gene express follow irradi goal then model data extract hidden variabl chiefli activ transcript factor inform predict transcript chang ir target cell log phase ml irradi gy room temperatur rt dose rate gy per minut cs irradi cell harvest hour rna protein extract trizol invitrogen affymetrix ua array hybrid standard wwwaffymetrixcouk array qualiti determin gcos rpt file valu time cours replic time independ cell prepar cell homo sapien molt cfarp cell acut lymphoblast leukemia
transcript human uterin fibroid normal myometrium defect mitochondri enzym predispos sever development defect well tumorigenesi heterozyg germlin mutat nuclear gene encod fumar hydratas fh enzym catalyz hydrat fumar kreb tricarboxyl acid cycl caus hereditari leiomyomatosi renal cell cancer connect between disrupt mitochondri metabol pathway neoplasia remain discov have express microarray approach studi differ global gene express pattern caus mutat fh seven uterin fibroid carri fh mutat compar fibroid wildtyp fh group show mark differ express multipl differenti express gene detect most signific increas fh mutant seen express carbohydr metabol glycolysisrel gene other signific upregul gene categori fh mutant exampl iron ion homeostasi oxidoreduct gene lower express fhmutant fibroid belong group such extracellular matrix cell adhes muscl develop cell contract show fh mutat alter signific express fibroid most strike increas express gene involv glycolysi uterin fibroid myometrium mutant fh control homo sapien patient patient patient patient patient patient patient patient patient patient patient uterin fibroid normal myometrium
transcript primari all cell tlineag sensit lasparaginas mtt vitro sensit assay primari all cell tlineag sensit lasparaginas mtt vitro sensit assay homo sapien
transcript human blood outgrowth endotheli cell patient sickl cell anemia predict stroke risk genet differ endotheli biolog could underli develop phenotyp heterogen amongst individu afflict vascular diseas obtain boec blood outgrowth endotheli cell subject sickl cell anemia age shown either atrisk notatrisk ischem stroke due respect have not have occlus diseas circl willi cow gene express identifi no signific singl gene differ between group expect howev analysi biolog system score gene predetermin survey nine biolog system show onli chang inflamm signal characterist atrisk subject support multipl statist approach experi obtain boec blood outgrowth endotheli cell subject sickl cell anemia age shown either atrisk notatrisk ischem stroke due respect have not have occlus diseas circl willi cow allow power calcul done perform microarray analysi boec normal subject divers age gene express obtain affymetrix ua chip homo sapien
shrna human ewe sarcoma sampl produc molecular function map ewinga sarcoma ewsfli chimer et transcript factor due chromosom rearrang specif express ewe sarcoma famili tumor esft thought initi event develop diseas previous genom experi have identifi number ewsfli regul gene gene discrimin esft other sarcoma so far comprehens analysi ewsfli depend molecular function character aggress cancer lack studi molecular function map esft construct base integr analysi gene express experi uniform microarray platform follow ewsfli knockdown panel five esft cell line gene express data same platform primari esft tumor base assumpt ewsfli drive transcript forc esft pathogenesi predict invers correl gene express ewsfli regul gene between putat tissu origin cell line under ewsfli knockdown condit consist recent report mesenchym progenitor cell mpc found fit hypothesi best therefor refer tissu construct molecular function map esft interrel molecular pathway visual measur similar among annot gene function gene share molecular function map highlight distinct cluster activ ewsfli regul gene esft reveal strike differ between ewsfli up downregul gene ewsfli induc gene main belong cell cycl regul prolifer respons dna damag while repress gene associ differenti cell communic studi reveal ewsfli combin distinct molecular mechan import function cellular transform protein growth promot differenti blockag take mpc refer tissu signific ewsfli signatur discov esft onli partial overlap previous publish ewsfli depend gene express pattern identifi seri novel target chimer protein esft result guid target select futur esft specif therapi experi ewsfli knock down perform express specif sirna against ewsfli small hairpin sh rnas psuperbas retrovir express construct differ ewe sarcoma cell line sknmc tc staet staet negat control cell line pstneg ambion appli biosystem brunn am gebirg austria encod scrambl shrna no signific similar human sequenc homo sapien
transcript human liver obes without type diabet lean human subject hepat lipid accumul import complic obes link risk type diabet identifi novel transcript chang human liver could contribut hepat lipid accumul associ insulin resist type diabet dm evalu gene express gene enrich surgic liver biopsi obes dm control subject obtain fast state time elect abdomin surgeri obes cholecystectomi rna isol crna prepar hybrid affymetrix ua microarray experi human liver sampl obtain lean control subject undergo elect cholecystectomi obes subject without type diabet undergo gastric bypass surgeri subject diabet classifi either wellcontrol poorlycontrol homo sapien
transcript time seri finit life span immort nonmalign human mammari epitheli cell line  analyz gene express finit life span hmt immort nonmalign hmec success day postseed lamininrich extracellular matrix assay both hmec underw growth arrest gg differenti polar acini between day adult mammari gland femal mammari epitheli frozensampl homo sapien hmts hmec hmec
transcript human blood outgrowth endotheli cell member kindr vermont cell adhes molecul cadm novel risk factor venous thrombosi protein pc defici increas risk venous thrombosi vt among member kindr vermont fail fulli account inherit pattern genom scan pedigre support presenc prothrombot gene chromosom weaker support chromosom pq preliminari data affimetrix microarray express analysi blood outgrowth endotheli cell member kindr vermont compar well establish normal control group indic igsf decreas patient versus control addit both statist pathway analysi result suggest these gene associ protein further studi indic cell adhes molecul cadm member igsf superfamili associ vt experi obtain boec blood outgrowth endotheli cell femal kindr subject age protein defici also perform microarray analysi boec normal subject divers age homo sapien
transcript human age hematopoiet progenitorstem cell  determin age impact gene express hematopoiet stem cell hscs human cd cell bone marrow bm mobil stem cell product pnpbsc examin microarraybas express differenti express chang confirm microarray comparison younger older expand tcell popul experi compar gene express between younger older human cd cell bone marrow bm cdcd cell mobil stem cell productspnpbsc also examin gene express chang associ age human expand tcell bm tcell biotinlabel total rna perform per standard affymetrix protocol pnpbsc array singlestrand linear amplif protocol process total rna nanogram microarray both protocol describ detail pmid homo sapien
transcript mesenchym stem cell msc maintain fcs autolog serum over time analys passag   purpos studi determin whether serum condit affect gene express mesenchym stem cell mscsover time end compar gene express mscs maintain regular growth medium supplement fetal calf serum fcs passag gene express mscs cultur same condit passag differ donor ie donor donor likewis compar gene express mscs maintain regular growth medium supplement autolog seruma passag gene express mscs cultur same condit passag same donor ie donor donor mscs cultur fcs assuppl medium analyz passag passag adult bone marrow male mesenchym stem cell freshsampl homo sapien donor donor 
transcript goat model cml  evalu longterm growth potenti bcrabltransduc primit human hematopoiet cell lin cord blood cell contain mscvbcrabliresgfp bcrabl controlgfp transgen mig inject ip fetal goat day gestat transplant goat born aliv examin week after birth show gfp cell blood bone marrow bm liver kidney lung heart both skelet smooth muscl fish analysi also show liver goat contain bcrablgfp transgen cell remain five goat appear normal although some wbc count elev fold gfp cell includ cell identifi fac human cd cell have been detect blood all these goat presenc bcrablgfp transgen cell bm liver confirm fish analysi quantit realtim pcr analysi genom dna isol unpurifi bm cell obtain transplant goat demonstr copi transgen per microgram dna microarray transcript perform blood liver tissu normal goat bcrabl chimer goat mig chimer goat normal human sampl rna human gene detect goat transplant cord blood cell not normal goat rna abund some gene bcrabl chimer goat blood similar greater than level observ mig goat blood normal human sampl quantit rtpcr confirm differenti express sever gene goat carri bcrabl vs control transgen these result demonstr longterm engraft slow expans larg anim model primit human hematopoiet cell transduc bcrabl fusion gene transplant utero novel xenotranspl goat model should analyz initi phase develop human cml assess new therapi potenti longterm benefit experi total rna extract liver blood sampl normal goat ng human hu chimer goat engraft human cord blood stem cell contain control mig vector chimer goat engraft cml bcrabl vector rna sampl affymetrix human ua genechip examin differenti express gene cml vs control goat filter signal signific abov background level observ normal goat select specif human gene express homo sapien capra hircus
transcript bone marrow sampl children acut lymphoblast leukemia identifi chang gene express associ current risk assign irrespect genet subtyp  analyz bone marrow sampl children acut lymphoblast leukemia identifi chang gene express associ current risk assign irrespect genet subtyp bone marrow male biopsi homo sapien acut lymphoblast leukemia
sirna melanoma cell line bl transfect sirnanrasqr transcript global character gene express alter result treatment melanoma cell sirna specif target nrasqr experi bl cell transfect sirna against either mutant nrasqr simut simut scrambl control sisc untransfect cell day baselin control cell transfect both simut sisc homo sapien
transcript human hematopoiet cell healthi donor leukem blast aml patient acut myeloid leukemia aml most common dead form hematopoiet malign hypothes microarray studi could identifi previous unrecogn express chang onli occur onli aml blast particular interest those gene increas express aml believ these gene potenti therapeut target experi compar gene express between normal hematopoiet cell healthi donor leukem blast aml patient normal hematopoiet sampl includ cd select cell unselect bone marrow unselect peripher blood homo sapien
transcript human pair gingiv ligament regener cell isol patient have been treat periodont regen surgic procedur periodont regener studi periodont common chronic inflammatori diseas lead tooth loss ultim goal periodont therapi complet regener tissu lost result periodont howev most regen clinic procedur unpredict larg becaus there lack understand various tissu compris periodontium gingiv epithelium gingiv connect tissu periodont ligament aveolar bone cementum interact dure regen process studi investig molecular mechan involv periodont regener purpos pair gingiv ligament regener cell isol patient have been treat periodont regen surgic procedur microarray analysi hua affymetrix array identifi gene pathway characterist differ tissu have identifi over transcript global comparison intrapati comparison differenti express between ligament gingiv sampl approxim transcript character regener cell popul function classif base gene ontolog abl group transcript group proteasesproteas inhibitor differenti express between ligament gingiva highlight high ecm remodel activ gingiv cell other hand ligament cell shown have increas protein synthesi increas their nucleolar ribosom gene complement abl identifi various dna bind protein among them some well characteris transcript factor transcript regul includ dna polymeras transcript coactiv furthermor have also identifi chang express their target tissu first studi characteris gene express periodont regener cell allow us gain valuabl insight cellular molecular mechan occur dure regen process have identifi signal pathway consist clinic observ regen properti gingiv periodont ligament cell these pathway provid candid target manipul order achiev superior regen clinic outcom homo sapien
transcript human osteosarcoma te cell line grown differ amino acidconjug surfac amino acid conjug surfac control hour homo sapien te osteosarcoma
transcript human huvec cell line infect neisseria meningitidi wild type mutant vs uninfect sampl time point reveal meningococc adhes suppress proapoptot gene express promot express gene support earli embryon cytoprotect signal human endotheli cell time cours gene express primari human umbil vein endotheli cell huvec dure infect piliat adher wildtyp wt frpcfrpadefici mutant nonadher pild neisseria meningitidi mc bacteria defect product type iv pilus analyz respect total rna isol uninfect huvec refer huvec after hour infect meningitidi mutant label accord standard affymetrix protocol hybrid hgua genechip data analyz robust multiarray analysi algorithm everi condit least biolog replic analyz total repres affymetrix genechip huvec homo sapien
transcript human primari all cell tlineag sensit vincristin mtt vitro sensit assay primari all cell tlineag sensit vincristin mtt vitro sensit assay homo sapien
transcript human fresh isol adiposederiv adult stem cell adasc vs cultur cell  order assess whether cultur adiposederiv adult stem cell adasc affect their gene express sampl growth condit protocol want identifi possibl gene differenti express between cultur polyclon cd adasc fresh isol uncultur polyclon cd adasc end rna isol cultur uncultur adasc differ donor analyz affymetrix microarray hgua then affymetrix program mas perform comparison could identifi differenti express transcript common between donor affymetrix program dmt adult adipos tissu abdomen adipos tissu abdomen thigh femal adiposederiv adult stem cell adasc freshsampl homo sapien donor donor donor fresh isol noncultur nc polyclon cd adasc cultur polyclon cd adasc year normal
transcript human fibriod vs normal myometrium mutat wild type fumar hydratas fh gene reveal distinct express fumaratehydratasedefici uterin fibroid  seri gene express measur normal myometrium uterin fibroid mutat wildtyp fumar hydratas fh gene uterin fibroid normal myometrium mutant fh wild type fh control homo sapien
transcript acut lymphoblast leukaemia patient sampl repres differ subgroup defin cytogenet featur immunophenotyp  examin publish microarray data acut lymphoblast leukaemia patient specimen repres differ subgroup defin cytogenet featur immunophenotyp decisiontre base supervis learn algorithm random forest rf determin small gene optim subgroup distinct subsequ valid their predict power independ cohort specimen assess affymetrix hgua array peripher blood bone marrow femal male mll telaml bcrabl hyperdip eapbx mll telaml bcrabl tall hyperdip eapbx cell cell homo sapien patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient patient year per du per per allsil per per per per cemccrf per per per per per per jurkat hsb molt per acut lymphoblast leukemia
transcript human tcell differenti  gain more insight initi regul cell receptor tcr gene rearrang dure human cell develop analyz tcr gene rearrang quantit pcr analysi nine consecut tcell development stage includ cd lin cord blood cell refer same stage gene express dna microarray blood frozensampl cdcda thymocyt cd umbil cord blood cell sp cd thymocyt dp cd thymocyt dp cd thymocyt isp cd thymocyt cdcd thymocyt cdcda thymocyt sp cd thymocyt homo sapien
transcript human melanoma cell line treat azadeoxycytidin identifi novel tumor suppressor gene silenc methyl melanoma malign melanoma common frequent lethal diseas current therapeut intervent have littl effect surviv emphas need better understand genet epigenet phenotyp chang melanoma format progress identifi gene not previous known silenc methyl melanoma microarraybas screen follow treatment melanoma cell line dna methyl inhibitor azadeoxycytidin experi rna isol follow hour azadc treatment melanocyt melanoma cell line meljuso uacc neo wm wm reexpress microarray analysi homo sapien
transcript human muscl normal extraocular  molecular definit human extraocular muscl eom human eom compar limb quadricep femori muscl homo sapien
transcript ebv infect human cell expos ngml tgf beta hour idiopath pulmonari fibrosi ipf refractori lethal interstiti lung diseas ebv previous been localis alveolar epitheli cell ipf patient molecular process epitheli mesenchym transit emt ipf remain still unknown oligonucleotid array analysi observ dysregul express member noncanon wnt famili ebv infect after tgf exposur tgf exposur induc emt increas smooth muscl actin actc wntb gene express decreas ecadherin dkk data analyz function wntb emt signific differ actc ecadherin gene express activ tgf protein level collagen deposit could detect treatment cis retino acid cisra signific inhibit wntb express both ebv infect noninfect follow decreas collagen deposit activ tgf protein level specif noncanon wntsignal gene dysregul ebv infect cell treat tgf while cisra treatment appear attenu emt process vitro experi ebv infect cell cultur rpmifc expos ngml tgf beta hour rna isol cdna synthesi vitro transcript microarray analysi perform previous report kieran et al all analysi microarray duplic imag file obtain through affymetrix genechip softwar mas subsequ robust multichip analysi rma perform express data compar control correl valu signal log ratio greater equival fold chang express greater taken identifi signific differenti regul bolstad et al all slrs data result compar analys duplic report scatter plot graph determin reliabl assay linear all microarray assay valu higher than normalis rma valu gene cluster softwar averag linkag hierarch cluster analysi perform treeview analysi softwar eisen et al list dysregul gene both tgf expos cell line curat public avail david geneontolog gochart function annot cluster databas denni et al homo sapien
transcript human paediatr acut lymphoblast leukaemia  address clinic signific mechan behind vitro cellular respons ionis radiat irinduc dna doubl strand break paediatr all patient found apoptosisresist respons patient apoptosissensit respons remain leukaemia global gene express apoptosisresist apoptosissensit all reveal abnorm upregul multipl prosurviv pathway respons ir apoptosisresist leukaemia differenti posttranscript activ piakt pathway observ repres resist case possibl abnorm prosurviv respons dna damag provid mechan primari resist all experi twenti bprecursor all tumour respons irinduc dna damag resist analys befor hour after exposur gy ir affymetrix hgua gpl platform homo sapien
transcript human anaplast larg cell lymphoma cell line kinas signatur anaplast larg cell lymphoma alcl repres subset lymphoma anaplast lymphoma kinas alk gene frequent fuse npm gene previous demonstr constitut phosphoryl alk chimer protein suffici induc cellular transform vitro vivo alk activ strict requir surviv alk posit alcl cell elucid signal pathway requir alkmedi transform tumor mainten analyz transcriptom multipl alk posit alcl cell line abrog their alkmedi signal induc alk rna interfer rnai potent cell permeabl alk inhibitor transcript deriv gene express gep analysi uncov reproduc signatur includ novel group alkregul gene function rnai screen these alk transcript target reveal transcript factor cebpb antiapoptot protein bcla absolut necessari induc cell transform andor sustain growth surviv alk posit alcl cell thus prove experiment control function valid gep analysi repres power tool identifi novel pathogenet network valid biolog suitabl target gene therapeut intervent experi seri microarray experi contain gene express anaplast larg cell lymphoma alcl cell line ts subclon supm sudhl engin express alka shrna under doxycyclineinduc promot treat cell permeabl pyrrolocarbazolederiv alk inhibitor mutat alkam shrna control briefli cell transduc plvdsredttrkrab expand transduct plvthgfpshrna lentivir particl cell induc doxycyclin microgml hour doubl gfp dsred cell select fluorescenceactiv cell sort cell express gfp absenc induc remov second flow cytometri sort expand shrna express induc doxycyclin treatment hour drug treatment nm perform ts cell alk inhibitor mock compound control diluent hour microgram total rna process hybrid affymetrix hgua chip follow manufactur instruct homo sapien
transcript human wrist muscl cerebr palsi patient cerebr palsi caus upper motor neuron lesion casu spastic well secondari effect muscl muscl cerebr palsi patient been shown smaller more ecm longer sarcomer length microarray global investig transcript adapt cerebr palsi muscl research muscl pathway alter diseas state experi muscl biopsi taken children undergo surgeri expos wrist muscl extensor flexor both cerebr palsi patient control patient rna extract hybrid affymetrix genechip cerebr palsi patient classifi number clinic score homo sapien
transcript human alveolar epitheli cell line infect ebv aakata reval alveolar epitheli cell injuri ebv upregul tgfbeta express idiopath pulmonari fibrosi ipf refractori lethal interstiti lung diseas character alveolar epitheli cell apoptosi fibroblast prolifer extracellular matrix protein deposit epstein barr virus ebv previous been localis alveolar epitheli cell ipf patient studi utilis microarray base differenti gene express analysi strategi identifi potenti molecular driver ebv associ lung fibrosi employ alveolar epitheli cell line infect ebv aakata lytic phase infect induc aakata cell tpaba treatment result increas tgfbeta tieg mrna express treatment aakata cell ganciclovir result down regul both tieg tgfbeta express accompani suppress ebv earli respons gene rta zta suppress cell turnov mediat correl increas cell activ index identifi possibl role rta drive apoptot gene express inhibit rta gene express silenc rna result decreas tgfbeta tieg express studi identifi apoptot role ebv earli respons gene enhanc factor tieg tgfbeta ebv infect alveolar epitheli cell potenti provid possibl mechan role ebv infect pulmonari fibrosi experi rna isol cdna synthesi vitro transcript microarray analysi ebv infect aakata tgfbeta ngml hour perform previous report all analysi microarray duplic imag file obtain through affymetrix genechip softwar mas subsequ robust multichip analysi rma perform express data compar control anova analysi correl valu signal log ratio greater equival fold chang express greater taken identifi signific differenti regul all slrs data result compar analys report graph determin reliabl assay linear all microarray assay valu higher than gene express valu normalis rma averag linkag hierarch cluster analysi perform result visual treeview softwar homo sapien
transcript human myeloid cell human myelopoiesi excit biolog model cellular differenti sinc repres plastic process where pluripot stem cell gradual limit their differenti potenti generat differ precursor cell final evolv distinct termin differenti cell studi investig genom express dure myeloid differenti through comput approach integr gene express function inform genom organ genom distribut myelopoiesi gene investig integr transcript function characterist gene analysi genom express dure human myelopoiesi integr comput approach allow discov import relationship between genom posit biolog function express pattern highlight chromatin domain includ gene coordin express lineagespecif function experi gene express data experi differ cell type human myelopoiet lineag generat integr myelopoiesi dataset homo sapien
transcript bone marrow children tcell acut lymphoblast leukamia oompar those remain continu complet remiss those relaps  compar gene express group children tcell acut lymphoblast leukamia remain continu complet remiss ccr group relaps affymetrix hgua array decisiontre base supervis learn algorithm random forest rf gene rank respect their abil discrimin between patient remain ccr those relaps toprank probe gene select further investig valid independ cohort tall patient quantit real time polymeras chain reaction bone marrow femal male cell homo sapien patient patient patient patient patient patient patient patient patient patient patient patient year white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl white blood cell count diagnosi xl cell acut lymphoblast leukemia
transcript human tcell acut lymphoblast leukemia tcell lymphoblast lymphoma bprecursor acut lymphoblast leukemia sampl tcell acut lymphoblast leukemia tall tcell lymphoblast lymphoma tll often thought repres spectrum singl diseas malign cell tall tll morpholog indistinguish they share express common cell surfac antigen cytogenet characterist howev despit these similar differ predomin site diseas tall tll observ determin under biolog distinct potenti contribut some these differ analyz global gene express malign tcell precursor ten tall nine tll dna array ten addit bprecursor all bone marrow sampl separ analysi brbr note file gsmtxt gsmtxt ident download geo lymphoid tissu bone marrow homo sapien tcell lymphoblast lymphoma tcell acut lymphoblast leukemia bprecursor acut lymphoblast leukemia
transcript human primari huvec immort huvec cell line treat atorvastatin andor mevalon rational immort cell exhibit import differ relat their primari cell counterpart microarray compar primari human umbil vein endotheli cell huvec immort huvec cell line eahy their respons inhibit mevalon pathway hmgcoa reductas inhibitor atorvastatin effect atorvastatin revers addit mevalon subtract nonspecif chang gene express method confluent cell cultur huvec eahy cell independ experi cell type incub statinfre media microm atorvastatin microm mevalon combin microm atorvastatin microm mevalon all cell harvest total rna isol trizol reagent invitrogen cdna prepar microgram total rna doublestrand cdna synthesi kit life technolog tdt primer firststrand synthesi crna synthes cdna biotinyl bioarray high yield rna transcript label kit enzo diagnost twenti microgram crna fragment heat min fragment buffer contain mm trisacet ph mm koac mm mgoac fifteen micrgram fragment crna togeth control crnas grid align oligonucleotid hybrid overnight genechip human genom ua array affymetrix under constant rotat array wash incub antistreptavidin antibodi fluoresc signal measur agil gene array laser scanner analyz microarray suit affymetrix microarray scale default umbil vein endotheli cell homo sapien primari cultur eahy
transcript human foreskin fibroblast grown multicellular spheroid monolay human foreskin fibroblast grown multicellular spheroid monolay adult skin male freshsampl fibroblast homo sapien hfsf
transcript human breast cancer cell line  measur baselin gene express panel breast cancer cell line affymetrix ua array freshsampl steve ethier ge gray lab georgetown atcc chris benz adi gazdar homo sapien hcc mdamb mdamb zrb summo hcc mdamb au hcc cama uacc hcc sump mcfa hcc hcc bt zr ly td zr hcc mdamb bt sump hcc sumcwn mdamb sumpt hbl sumpt mdamb hcc mdambvi bt hcc sumpt mdamb mdamb hcc mcfa mcf mdambvii hcc sump mpe hcc hcc skbr bt hst
transcript mous undifferenti cc myoblast day differenti myotub comparison undifferenti cc myoblast day differenti myotub experi experi includ sampl replic mus musculus
transcript human all sampl veri earli relaps childhood patient purpos childhood acut lymphoblast leukemia all approxim patient suffer relaps recurr diseas despit intensifi therapi cure rate remain unsatisfactori surviv rate particular poor certain subgroup probabl longterm surviv after relaps predict wellestablish prognost factor time site relaps immunophenotyp minim residu diseas howev under biolog determin these prognost factor remain poor understood result show patient veri earli relaps all character distinct gene express pattern identifi gene differenti express veri earli relaps all compar late relaps diseas vast major gene upregul mani late cell cycl gene function mitosi addit sampl patient veri earli relaps show signific increas percentag gm phase cell correl well express level cell cycl gene conclus veri earli relaps all character increas prolif capac leukem blast upregul mitot gene latter suggest novel drug target late cell cycl protein might benefici these patient typic face dismal prognosi experi perform gene express prospect collect sampl children first relaps acut lymphoblast leukemia enrol relaps trial allrez bfm berlinfrankfurtmuenst studi group homo sapien
transcript human cell type infect dengu virus reveal trail novel antivir protein against dengu virus dengu fever import tropic ill there current no virusspecif treatment shed light mechan involv cellular respons dengu virus dv assess gene express chang affymetrix genechip hgua infect primari human cell identifi chang common all cell common respons gene includ gene signific induc upon dv infect human umbil vein endotheli cell huvec dendrit cell dcs monocyt cell analysi varianc tumor necrosi factorrel apoptosisinduc ligand trail common respons gene identifi key link between type type interferon respons gene found dv induc trail express immun cell huvec mrna protein level induct trail express dv found depend intact type interferon signal pathway signific increas dv rna accumul observ antitrail antibodytr monocyt cell huvec convers decreas dv rna seen recombin trailtreat monocyt furthermor recombin trail inhibit dv titer dvinfect dcs apoptosisindepend mechan these data suggest trail play import role antivir respons dv infect candid antivir intervent against dv affymetrix microarray studi respons human host cell dengu virus dv experi human cell type rna extract hybrid affymetrix microarray compar total sampl five infect vitro hour dv includ huvec monocyt bcell five mockinfect control same cell type number these sampl identifi gene induc dv infect all cell type homo sapien
transcript human lung cancer cell line anticanc drug cluster lung cancer base gene express perform gene express analysi lung cancer cell line affymetrix genechip human genom array hgua also examin sensit these cell line common anticanc agent docetaxel paclitaxel gemcitabin vinorelbin fu sn cisplatin carboplatin mtt assay relat cytox activ these agent correspond express pattern cell line modifi nci program experi gene express analysi lung cancer cell line homo sapien pc lu sbc lu rerflcai lu ebc pc lk abc pc ms lcf pc sbc rerflckj lcad lcsq pc lu pc pc qg sq rerflcm lu small cell cancer squamous cell cancer nonsmal cell adenocarcinoma
transcript human primari all cell blineag sensit lasparaginas mtt vitro sensit assay primari all cell blineag sensit lasparaginas mtt vitro sensit assay homo sapien
transcript human estrogen receptor posit mcf cell stabli transfect aromatas gene treat testosteron bestradiol aromatas inhibitor letrozol anastrozol antiestrogen tamoxifen antiestrogen aromatas inhibitor import drug treatment estrogendepend breast cancer order investig effect these drug gene express breast cancer cell treat estrogen receptorposit mcf cell stabli transfect aromatas gene known mcfaro cell testosteron estradiol aromatas inhibitor letrozol anastrozol antiestrogen tamoxifen microarray analys affymetrix human genom ua genechip carri out total rna isol control treat cell compar effect inhibitor gene express observ letrozol anastrozol more similar term gene they affect compar treatment tamoxifen result studi provid us better understand action both aromatas inhibitor antiestrogen molecular level believ result studi serv first step identifi uniqu express pattern follow drug treatment will ultim custom patient treatment strategi estrogendepend breast cancer data present have been process rproject bioconductor statist tool packag affi librari follow appli rma background correct pmon probelevel correct quantil normal avgdiff summari method raw data provid form cel file estrogen receptor posit cell homo sapien mcfaro cell
sirna human lncap cell overexpressingknockdown hoxc  transcript factor hoxc upregul human prostat cancer sirna knockdown hoxc induc apoptosi lncap cell while upregul rescu lncap cell sirnainduc apoptosi microarray identifi gene whose express under antiapoptot prolif effect hoxc lncap cell experi lncap cell transient transfect cocktail sirna hoxc final concentr nm hoxc gene express vector control sirna vector cell collect hour posttransfect homo sapien
transcript human cell absenc mitochondri dna mitochondri biogenesi under control differ genet system nuclear genom ndna mitochondri genom mtdna mtdna circular genom kb encod approxim subunit form respiratori chain remain encod nuclear genom ndna eukaryot cell abl monitor respond chang mitochondri function through alter nuclear gene express phenomenon first defin yeast known retrograd regul experi identifi nuclear gene signific chang their express level respons deplet mtdna experi affymetrix hgua genechip studi transcriptom human cell line btk been entir deplet mtdna rho cell compar correspond undeplet parent cell rho cell independ biolog replic analyz cell line treatment group homo sapien
transcript human primari all cell tlineag resist prednisolon mtt vitro sensit assay primari all cell tlineag resist prednisolon mtt vitro sensit assay homo sapien
transcript nude mice tumor biopsi generat inject mesenchym stem cell msc transform msc inject subcutan flank athym cd nude mice criver biopsi cm spindl cell tumour taken transform freshsampl homo sapien spindl cell tumor
transcript human tall patient diagnosi relaps  sampl affymetrix ua microarraysbr br nineti patient tall diagnos treat saintloui hospit pari seven patient studi diagnosi relaps total tall sampl there children median age year old rang adult median age rang inform consent obtain patient andor relat tall diagnosi base morpholog immunophenotyp criteria flow cytometri extend monoclon antibodi panelbr br combin molecular cytogenet largescal express analysi human tall identifi character new recurr chromosom transloc target major homeobox gene cluster hoxa tcrb locus specif quantit pcr analysi show express whole hoxa gene cluster dramat dysregul hoxarearrang case also mll calmafrel tall case strong suggest hoxa gene oncogen these leukemia inclus hoxatransloc case general molecular portrait tall base largescal express analysi show rearrang defin new homogen subgroup share common biolog network tlx tlxrelat case sinc tall deriv tcell progenitor express distinct tall subgroup analyz respect those normal human thymic subpopul inappropri util perturb specif molecular network involv thymic differenti detect moreov found signific associ between tall oncogen subgroup ectop express limit gene includ sever development gene name hoxa tlx tlx nkx tfapc these data strong support view abnorm express development gene includ prototyp homeobox gene hoxa critic tall oncogenesisbr br project leader br fran oi sigauxbr institut universitair dhematologiebr hopit saint loui pari francebr br data submissionbr fabien petelbr programm cart didentit des tumeur citbr ligu national contr le cancer pari franc thymus peripher blood bone marrow femal male tcell line unpurifi thymus cell frozensampl hopit saintloui pari homo sapien tl tl tl tl tl tl tl cem jurkat hsb molt year relaps initi present precursor lymphoblast leukemia
transcript human breat cancer cell line reveal xbp confer estrogen independ antiestrogen resist human xbox bind protein xbp altern splice transcript factor particip unfold protein respons upr stress signal pathway allow cell surviv accumul unfold protein endoplasm reticulum lumen have previous demonstr xbp express increas antiestrogenresist breast cancer cell line coexpress estrogen receptor alpha er breast tumor purpos studi investig role xbp upr estrogen antiestrogen respons breast cancer overexpress splice xbp xbps erposit breast cancer cell lead estrogenindepend growth reduc sensit growth inhibit induc antiestrogen tamoxifen faslodex manner independ function data gene express microarray analys impli xbps act through regul express er antiapoptot gene bcl sever other gene associ control cell cycl apoptosi experi total rna isol independ cultur cell popul grown differ day differ stock mcfxbp cultur vector control cultur miam compliant data collect recommend microarray gene express data mged societi rna concentr determin compar optic densiti ratio nm data rna qualiti obtain agil bioanalyz rna labchip kit agil technolog new castl de rna qualiti assess visual inspect electropherogram bioanalyz data calcul rna integr number rin degradomet valu onli high qualiti total rna label hybrid ua affymetrix genechip manufactur recommend procedur affymetrix santa clara ca standard spikedin control also includ hybrid homo sapien
transcript human prostat cancer cell arachidon acid reveal induct gene regul nfkappab essenti fatti acid fa not onli energyrich molecul they also import compon membran bilay recent have been implic induct fatti acid synthas fas other gene gene chip analysi have found arachidon acid aa omega fatti acid induc gene regul nfkappab verifi gene induct omega fatti acid includ cox ikba nfkb gmcsf ilb cxcl tnfa il lta il pparg icam qrtpcr pge synthesi increas within min addit aa analysi upstream signal transduct show within min fa addit phophatidylinositol kinas pik signific activ follow activ akt min erk sapkjnk not phosphoryl after omega fa addit thirti minut after fa addit found signific fold increas transloc nfkappab transcript factor nucleus addit nonsteroid antiinflammatori drug nsaid caus decreas cox protein synthesi pge synthesi well inhibit pik activ have previous shown aa induc prolifer also block pik inhibitor ly ly also signific inhibit aa induc gene express cox ilb gmcsf icam taken togeth data suggest aa convers pge play import role stimul growth relat gene prolifer pik signal nfkappab transloc nucleus homo sapien pc prostat cancer
transcript human primari all cell blineag sensit vincristin mtt vitro sensit assay primari all cell blineag sensit vincristin mtt vitro sensit assay homo sapien
transcript human adult postmortem brain tissu down syndrom healthi control subject down syndrom ds result trisomi chromosom mechan genotyp lead characterist diseas phenotyp unclear perform microarray studi human adult brain tissu dorsolater prefront cortex ds subject healthi control characteris first time human adult down syndrom brain experi rna extract human postmortem brain tissu adult subject down syndrom healthi control hybridis affymetrix hgua genechip identifi differenti express gene diseas state year year year year year year year year year year year year brain femal male homo sapien braak stage braak stage unknown braak stage vi braak stage vi braak stage braak stage unknown braak stage post mortem interv post mortem interv post mortem interv post mortem interv post mortem interv post mortem interv post mortem interv post mortem interv unknown post mortem interv post mortem interv post mortem interv caus death cardiac caus death aortic aneurysm caus death unknown caus death lung cancer caus death bronchopnuemonia caus death unknown down syndrom normal
transcript human prostat cancer primari cell line vs metastasi cell line reveal protein suppress prostat cancer progress metastasi protein ezrinradixinmoesin ferm domaincontain protein whose express frequent lost varieti human tumor includ meningioma nonsmallcel lung cancer breast carcinoma howev potenti tumor suppress function under vivo condit remain valid screen gene involv prostat cancer metastasi found express reduc high metastat tumor downregul increas metastat propens poor metastat cell orthotop model prostat cancer furthermor bdefici mice display increas suscept develop aggress spontan prostat carcinoma both case enhanc tumor malign associ reduc apoptosi express protein frequent downregul human clinic prostat cancer well spectrum other tumor type these result suggest more general role protein negat regul cancer progress metastat diseas experi primari cell line vs metastasi cell line homo sapien
transcript human nsclc cell line treat trichostatin vorinostat test antitumor activ histon deacetylas inhibitor  order ascertain potenti histon deacetylas hdac inhibitorbas treatment nonsmal cell lung cancer nsclc analyz antitumour effect trichostatin tsa suberoylanilid hydroxam acid vorinostat panel nsclc cell line mtt assay tsa vorinostat both display strong antitumor activ proport nsclc cell line suggest need predict marker select patient receiv treatment there strong correl between respons tsa vorinostat identifi molecular model sensit hdac inhibitor treatment nsclc conduct gene express studi cdna array same cell line relat cytotox activ tsa correspond gene express pattern modifi nci program addit pathway analysi perform pathway architect softwar nine gene identifi genedrug sensit correl pathway analysi build support vector machin svm algorithm model sensit cell line distinguish resist cell line predict perform svm model valid addit seven cell line result predict valu respect determin respons tsa result suggest hdac inhibitor promis anticanc drug nsclc nine gene classif predict drug sensit hdac inhibitor contribut achiev individu therapi nsclc patient train sampl gsm pc gsm pc gsm pc gsm gsm lk gsm rerf lckj gsm rerf lcms gsm rerflcai gsm pc gsm pc gsm pc gsm abc gsm ebc gsm lcad gsm sq gsm qg test sampl gsm lu gsm lcsq gsm lcf gsm lcok gsm lcd gsm gsm experi gene express analyi lung cancer cell line homo sapien
rnai human mdamb cell knock down rhogdibeta rhogdibeta arhgdib often express tumor cell negat regul rhogtpas have other function well analyz effect gene express rhogdibeta suppress rna interfer mdamb breast cancer cell chang gene express monitor cdna microarray experi mdamb cell either transfect rhogdibetaspecif sirna control sirna siluc grown day harvest lyse total rna isol rna subject cdna microarray analysi affymetrix chip hgua total independ transfect experi perform sampl obtain experi silucrep silucrep silucrep siluc transfect siarhrep siarhrep siarhrep sirhogdibeta transfect respect homo sapien
transcript human atyp tall despit improv therapi approxim onefifth children acut tlymphoblast leukemia tall succumb diseas suggest unrecogn biolog heterogen contribut drug resist studi leukem cell collect diagnosi identifi featur could defin highrisk subgroup total patient tall treat consecut institut their leukem cell examin multiparamet flow cytometri singl nucleotid polymorph array other method genom analysi surviv rate probabl treatment failur calcul subgroup consid have biolog distinct form tall lymphoblast patient immunophenotyp clear differ those remain patient most strike featur low absent express common tlineag marker cd cda cd express myeloid stem cell marker suggest stemcel like properti these atyp blast also show distinct gene express increas genom instabl patient form tall veri low probabl surviv year after diagnosi mean se versus all other patient cumul incid remiss failur hematolog relaps versus subset children tall have atyp blast cell immunophenotyp predict dire outcom standard intens chemotherapi altern treatment strategi need patient sybtyp leukemia experi diagnost tall sampl analyz homo sapien
transcript bcrabl cell cml patient chronic phase blast crisi identifi differenti express stagespecif gene  cd bcrabl cell cml patient chronic phase blast crisi identifi differenti express stagespecif gene adult blood male femal cd homo sapien year myeloidlymphoid blast crisi sampl taken befor treatment myeloid blast crisi chronic myelogen leukemia
transcript human embryon rhabdomyosarcoma emr cultur identifi paxfkhr regul gene differenti express between alveolar embryon rhabdomyosarcoma  goal object studi degre paxfkhr account differ between arm erm express construct term pfker consist paxfkhr join estrogen receptor ligand bind domain erm cell cultur system experi studi popul rd erm cell express pfker treat without nm hydroxytamoxifen control popul transduc vector onli pk similar treat homo sapien
transcript human macacqu liver muscl tissu  experi perform improv gene express analysi nonhuman primat human microarray improv interpret crossspeci hybrid probe match tabl creat valid tabl compar gene express data obtain human fasciculari tissu comparison liver muscl adult skelet muscl liver muscl mixedsex femal male biopsi macaca fasciculari homo sapien year caucasian normal congest heart failur intracrani hemorrhag nos sudden death
transcript human trabecular meshwork cell after tgfbeta treatment tgfbeta level known increas aqueous humor eye cell patient glaucoma increas tgfbeta assum have biochem impact trabecular meshwork increas extracellular matrix format respons decreas outflow facil eye increas extracellular pressur caus glaucoma tgfbeta caus abnorm accumul extracellular matric trabecular meshwork eye primari open angl glaucoma transform growth factor tgfbeta regul express proteoglycan aqueous humor human glaucomat eye identifi gene express chang result tgfbeta treatment human trabecular meshwork cell expect chang express proteoglycan htm cell respons tgfbeta treatment human trabecular meswork cell eye bath aqueous humor tm cell remov individu follow age individu treat etoh control tgfbeta tgfbeta total rna individu pool chip technic replic creat treatment type total chip homo sapien
transcript human tall patient cog studi   clinic cytogenet featur associ tcell acut lymphoblast leukemia tall not predict earli treatment failur base hypothesi microarray might identifi patient fail therapi affymetrix plus chip predict analysi microarray pam newli diagnos patient treat children oncolog group cog tall studi identifi member genom classifi could accur distinguish all induct failur case patient achiev remiss network analys suggest promin role gene mediat cellular quiescenc seven gene similar upregul both genom classifi patient tall cell line have acquir resist neoplast agent identifi potenti target gene further studi drug resist test whether classifi could predict within patient sampl obtain cog pam defin smaller classifi ua chip correct identifi singl case patient persist circul blast genet identifi tall patient like fail induct whom altern treatment strategi might benefici experi casecontrol retrospect studi perform express patient tall treat children oncolog group studi patient patient experi express obtain patient newli diagnos tall nr no respons induct failur failur relaps complet contin remiss experi note failur relaps sampl remov reason failur other than relaps homo sapien
transcript human primari all cell tlineag sensit prednisolon mtt vitro sensit assay primari all cell tlineag sensit prednisolon mtt vitro sensit assay homo sapien
transcript human lymphoblastoid cell line hapmap cell line ceu jptchb yri treat anticanc agent fluorouracil fu methotrex mtx simvastatin saha mercaptopurin mp rapamycin bortezomib lymphoblastoid cell line lcls origin collect renew sourc dna now model system studi genotypephenotyp relationship human cell these cell line have been search genet variant associ drug respons well more basic cellular trait such rna level out extend such studi search genet variant contribut drug respons observ phenotyp lcls lab other signific affect experiment confound ie vitro growth rate metabol state relat level epsteinbarr virus transform cell not find ani snps associ genomewid signific drug respons evalu whether incorpor rna express level eqtl analysi could increas power detect such effect previous shown cisact eqtl detect sizeabl fraction rnas baselin level mani rnas predict respons sever drug howev found onli limit evid snps influenc drug respons through their effect express rna effort lcls map gene under cellular trait will requir great care control experiment confound unbias method integr interpret such multidimension data much larger sampl size than have been appli date experi studi cell line dens genotyp intern hapmap project cell line cultur character baselin varieti cellular phenotyp includ growth rate atp level mitochondri dna copi number ebv copi number measur bcell relev cell surfac receptor cytokin level cell line expos well plate rang dose seven drug select base their diverg mechan action import clinic treatment bcell diseas focus anticanc agent fluorouracil fu methotrex mtx simvastatin saha mercaptopurin mp rapamycin bortezomib drug respons measur celltit glo atpactiv intracellular luminesc marker compar mocktreat control well repres relat level cellular viabil metabol activ rna collect baselin rna transcript level measur genomewid affymetrix platform baselin character plate drug respons experi perform batch cell line hapmap analysi panel ceu jpt chb yri experi day order cell line within panel random avoid induc artifici intrafamili correl drug test rang dose around expect ic report drug nci dtp dose drug test well per plate separ plate these replic measur cell line allow assess intraexperiment variat evalu daytoday ie interexperiment variat all trait subset cell line hapmap panel grown fresh aliquot entir experi repeat evalu effect technic error measur rna level rnas previous express illumina humanchip wellcom trust sanger institut wtsi generous provid emmanouil dermatsaki includ express broad affymetrix array data download broad institut web site httpwwwbroadmiteduyelenskycelllinespap pleas materi method detail qc normal etc pan troglodyt homo sapien
transcript human primari all cell tlineag sensit daunorubicinbi mtt vitro sensit assay primari all cell tlineag sensit daunorubicinbi mtt vitro sensit assay homo sapien
transcript human childhood acut lymphoblast leukemia identifi germlin mutat  identifi germlin singl nucleotid polymorph snps associ childhood acut lymphoblast leukemia all subtyp affymetrix map array public avail genotyp identifi snps whose allel frequenc differ px between pediatr all popul nonal control these snps differ allel frequenc among four all subtyp snps aridb not onli differ between all nonal group rs px odd ratioor rs px also distinguish bhyperdiploid all other subtyp rs rs these aridb snps also distinguish bhyperdiploid all other subtyp independ valid cohort children all respect associ methotrex accumul gene express pattern leukem lymphoblast conclud germlin genom variat affect suscept characterist specif all subtyp experi microarray detail global program gene express primari leukem blast cell children diagnos acut lymphoblast leukemia homo sapien
transcript all cell resist prednisalon primari all cell blineag resist prednisolon mtt vitro sensit assay homo sapien
transcript human all patient first bone marrow relaps gene express analyz children first bone marrow relaps gene pathway differenti earli vs late relaps identifi signatur predict earli respons therapi also identifi experi patient relaps analyz homo sapien
transcript human primari all cell tlineag resist daunorubicin mtt vitro sensit assay primari all cell tlineag resist daunorubicin mtt vitro sensit assay homo sapien
transcript human radioresist tumor xenograft athym nude mice detect gene differenti express radioresist tumor nu radiationresist human tumor xenograft select parent radiosensit tumor scc eight serial cycl passag athym nude mice vivo irradi obtain tumor affymetrix ua array most abund gene pattern associ radioresist phenotyp present ifninduc statdepend pathway experi obtain tumor establish xenograft nude mice rna purifi xenograft normal concentr sampl rna group pool hybrid array array group homo sapien
transcript human drug sensit resist all cell obtain diagnosi patient cellular drug resist associ unfavor prognosi pediatr acut lymphoblast leukemia all identifi gene confer resist antileukem agent analyz express gene sensit resist all cell obtain diagnosi patient reveal gene differenti express blineag all sensit versus resist prednisolon vincristin asparaginas daunorubicin respect predict accuraci notabl discrimin gene have not been previous associ resist these anticanc agent these includ carbohydratemetabol transcriptionassoci gene prednisolon cytoskeleton extracellular matrix gene vincristin ribosom protein translationassoci gene asparaginas ras signal nucleosom remodel complex gene daunorubicin identif novel genom determin cellular drug resist provid new insight overcom drug resist acut lymphoblast leukemia homo sapien
transcript human lung cancer cell their isogen mitochondri dna mtdnadeplet rho zero counterpart grown cell cultur tumor xenograft immunedefici mice interact between gene product encod mitochondri nuclear genom play critic role normal eukaryot cellular function character metabol transcript properti lung cancer cell their isogen mitochondri dna mtdnadeplet rho zero counterpart grown cell cultur tumor xenograft immunedefici mice manuscript summar conclus under review experi rho zero their parent cell grown cultur xenograft nude mice all experi conduct cultur perform triplic experi total all experi conduct xenograft perform quadrupl experi total manuscript summar experiment under review homo sapien
transcript human parent parent line mdamb fusion cell line indic hybrid assimil organspecif metastasi gene signatur both parent cell spontan cell fusion mdamb bonemetastat sublin bm ie scp lung metastat sublin lm ie lm gave rise hybrid line blmfac blmdrug well singl clone hybrid acquir metastasi tropism both parent cell express parent cell hybrid sever previous character mdamb metastat deriv compar hierarch cluster show hybrid assimil organspecif metastasi gene signatur both parent cell experi twentysix cell line analyz includ parent line mdamb cell fusion partner line bm lm selffus line bbm llm heterofus line blmfac blmdrug clone blmdrug strong bonemetastat line scp scp scp scp strong lungmetastat line weak metastat line scp scp scp scp scp scp singl sampl line homo sapien
transcript human all patient first bone marrow relaps without initi diagnosi  superseri compris follow subset seri gse patient diagnosi relaps gse sampl obtain relaps experi refer individu seri homo sapien
transcript human non small cell carcinoma cell line reveal synergi between ppargamma ligand platinumbas drug cancer ppar member nuclear receptor famili agonist ligand have antigrowth effect howev clinic studi ppar ligand monotherapi fail show benefici effect have studi effect ppar activ chemotherapeut agent current specif cancer observ strike synergi between rosiglitazon platinumbas drug sever differ cancer both vitro transplant chemic induc spontan tumor model effect appear due part ppar mediat downregul metallothionein protein have been shown involv resist platinumbas therapi these data strong suggest combin ppar agonist platinumbas drug treatment certain human cancer experi cell treat either dmsocontrol rosiglitazon carboplatin combin rosiglitazon carboplatin duplic hr rna isol microarray analysi carri out danafarb cancer institut microarray core homo sapien 
transcript human intervertebr disc cell treat vari osmolar growth medium human intervertebr disc tissu obtain patient averag age yrs undergo surgeri lumbar interbodi fusion lumbar disc herniat cell isol sequenti pronasecollagenas digest cell passag twice monolay suspend densiti cellsml algin low viscos sigma chemic st loui mo dissolv mm nacl algin bead form dropwis addit algin gaug needl mm cacl follow minut cure describ previous cellgel bead incub cell cultur media consist ham medium gibco brl grand island ny supplement fbs hyclon logan ut gml ascorb acid sigma st loui mo uml penicillin gml streptomycin gml fungizon co after cell cultur medium remov pipett exchang osmot activ solut repres isoosmot hyperosmot hypoosmot media isoosmot solut consist defin cell cultur medium ham supplement describ abov mosmkg ho hypoosmot solut consist same cell cultur media dilut deioniz water final osmolar mosmkg ho hyperosmot solut consist same cell cultur media supplement sucros final osmolar mosmkg osmolar all solut formul determin freezingpoint osmomet advanc laboratori wide rang advanc instrument needham height ma describ previous cellalgin bead cultur hour period under these condit after cell releas algin dissolv buffer mm nacitr mm nacl lyse store intervertebr disc ivd cell experi broad rang physic stimuli under physiolog condit includ alter their osmot environ studi gene express human ivd cell quantifi gene array technolog follow exposur vari osmolar order captur biolog respons broad target total gene identifi ivd cell signific chang follow cultur under hyperosmot condit while total gene identifi signific chang under hypoosmot condit gene express pattern verifi rtpcr gene identifi studi includ those relat cytoskeleton remodel stabil ephrinb sarcoglycan beta iqgap well membran transport ion transport slca osmolyt tranport slca monocarboxyl acid slca amino acid transport slca unexpect find differenti regul gene neurotrophin brainderiv neurotroph factor hyperosmot stimuli indic physiolog respons ivd cell physic stimuli import regul discogen pain year year year year spine disc intervertebr disc cell homo sapien
transcript human all patient diagnosi relaps  pair sampl initi diagnosi first marrow relaps gene pathway differenti diagnosi relaps identifi potenti therapeut target also identifi experi patient sampl initi diagnosi first marrow relaps homo sapien
transcript human aortic smooth muscl cell expos hypoxia system arteri smooth muscl cell expos broad rang oxygen concentr under physiolog condit hypoxia modul prolif respons smooth muscl cell lead specul about role vasculogenesi vascular remodel pathogenesi arteri diseas effect hypoxia been inconsist howev both enhanc prolifer growth arrest report nevertheless these report support import effect hypoxia smooth muscl cell prolifer given physiolog clinic relev requir clarif posit variat concentr within rang exist vivo have differ effect prolifer surviv vascular smooth muscl cell experi human aortic smooth muscl cell hasmc propag passag smgm medium reach confluenc media chang cell incub further hrs hrs under either normox hypox condit homo sapien
transcript human skov ovarian cancer cell reveal hepatocyt growth factor target sensit ovarian cancer cell cisplatin advanc ovarian cancer initi respons chemotherapi platinum drug develop drug resist most case show recent hepatocyt growth factor hgf enhanc death human ovarian cancer cell line treat cisplatin cddp effect mediat mitogenactiv protein kinas work integr genomewid express silico data survey function assay identifi transcript regul skov ovarian cancer cell made more respons cddp hgf oligonucleotid microarray found hgf pretreat chang transcript respons cddp quantit revers transcriptionpcr not onli valid all most differenti express gene also confirm they primarili modul combin treatment hgf cddp revers suppress mitogenactiv protein kinas activ among differenti express gene focus function analysi regulatori subunit protein phosphatas downmodul hgf plus cddp decreas subunit rna interfer made ovarian cancer cell more respons cddp mimick effect hgf conclus show hgf cddp modul transcript ovarian cancer cell transcript respons involv apoptosi regul also provid proofofconcept identifi gene might target either increas efficaci chemotherapeut revert chemotherapi resist experi timecours experi done independ experi tr tr analyz experi time experi time hour experi time hour experi time hour experi hgf without addit hgf hgf homo sapien
transcript human primari all cell blineag resist daunorubicin mtt vitro sensit assaydnr resist ball primari all cell blineag resist daunorubicin mtt vitro sensit assay homo sapien
transcript human brain total rna vs univers human refer rna differ commerci avail microarray commerci avail human genom microarray four differ manufactur compar human brain total rna against univers human refer rna both commerci avail prepar differ start amount amount rna replic perform human brain total rna label cy univers human refer rna label cy label then revers dye flip creat anoth replic meant four manufactur there total array imag process perform differ softwar packag data normal differ strategi addit spot array assay also perform same rna start materi situ synthesis oligonucleotid array human genom array these carri out independ laboratori first prepar array replic rna second lab rang rna start amount either prepar array amount total therefor there situ synthesis oligonucleotid array brain femal frozensampl homo sapien year
transcript human wild type deltatorcontain hepatocytelik cell compar total rna polysomebound rna popul upon hepatocyt differenti comparison total rna polysomebound rna popul deltat contain cell control cell upon hepatocyitc differenti transfect prolif liver hepatocytelik wildtyp deltat empti vector freshsampl differenti homo sapien heparg isol peritumor area edmondson grade hcc
transcript human primari all cell blineag sensit daunorubicin mtt vitro sensit assay primari all cell blineag sensit daunorubicin mtt vitro sensit assay homo sapien
transcript human umbil vein endotheli cell huvec stimul tnf vs control reveal tnf induc distinct express program huvec left untreat stimul ngml tnf compars gene reveal tnfmediat gene express chang huvec human umbil vein endotheli cell homo sapien
transcript human conjunctiv epitheli cell line human conjunctiv cell line tool model ocular surfac diseas evalu ocular drug demonstr iobanhc chwk conjunctiv epitheli cell line show unbias gene microarray approach uniqu gene express signatur differ primari conjunctiv epitheli cell pcec conjunctiv tissu global express obtain affymetrix ua chip gene pcec cluster more close conjunctiv tissu than either cell line howev restrict gene ontolog subcategori cellular defens viral replicationcycl antigen present antioxid pathway ubiquitin ligas complex cell line correl reason well pcec categori respons inflamm correl cell line pcec poor iobanhc chwk respect general express iobanhc cell better correl pcec than chwk cell statist signific consid all gene chip protein extracellular region respons wound stress lipid protein organ acid metabol develop differenti result choic conjunctiv cell line necessari futur experi increas valid extrapol clinic scenario experi affymetrix ua genechip experi experiment sampl experi iobanhc cell sampl experi chang conjunctiv epitheli cell wk deriv sampl experi primari conjunctiv epitheli cell explant sampl obtain cadaver human explant experi conjunctiv tissu pterygium studi where small piec uninvolv conjunctiva harvest patient rna pool form sampl total number sampl experi rt hybridis hr accord affymetrix protocol experi label biotin experi wash microfluid station experi analysi genespr gx experi rma normalis follow normalis chip level median signal experi these process data correl analysi experi further gene level normalis primari conjunctiv epitheli cell sampl purpos fold chang analysi compar express ioba chwk cell vs primari conjunctiv epitheli cell homo sapien
transcript primari all cell blineag resist vincristin mtt vitro sensit assay primari all cell blineag resist vincristin mtt vitro sensit assay homo sapien
transcript human primari all cell blineag sensit prednisolon mtt vitro sensit assay primari all cell blineag sensit prednisolon mtt vitro sensit assay homo sapien
rnai knock down rna bind imp protein human epitheli hela cell  identifi factor pathway regul imp protein obtain lead mechan behind phenotyp chang compar gene express imp sirna treat cell mock treat cell triplic gene express generat both impa impb sirna compar mock transfect cell crna hybrid affymetrix human ua array transfect epitheli homo sapien hela
transcript human lasparaginas drug resist acut lymphoblast leukemia cell primari all cell tlineag resist lasparaginas mtt vitro sensit assay homo sapien
transcript human all exhibit crossresist prednisolon vincristin asparaginas daunorubicinchemotherapi crossresist treatment respons childhood acut lymphoblast leukemia acut lymphoblast leukemia all cure combin chemotherapi over children caus treatment failur remain patient unknown determin sensit all cell individu antileukem agent patient genomewid approach identifi gene differenti express all exhibit crossresist prednisolon vincristin asparaginas daunorubicin also identifi distinct phenotyp discord resist asparaginas vincristin gene whose express associ novel phenotyp express these gene discrimin treatment outcom independ patient popul identifi subset patient mark inferior outcom year dfs homo sapien
transcript human primari all cell blineag resist lasparaginas mtt vitro sensit assay primari all cell blineag resist lasparaginas mtt vitro sensit assay homo sapien
transcript human radioresist radiosensit tumor cell line  superseri compos follow subset seri gse detect gene differenti express radioresist tumor gse detect gene differenti express radioresist radiosensit tumor befor after irradi gse interferon respons radioresist radiosensit human headneck tumor cell line experi refer individu seri homo sapien
